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Abstract
Decades of studies have examined the mechanisms by which drugs of abuse produce
strong rewarding eects that drive addictive behavior. However, these drugs also
produce aversive eects that are less well understood, but that also strongly inuence
drug-seeking, and may contribute to individual variation in addiction liability. For
example, individuals with particularly strong aversive responses to nicotine or alcohol
may be less likely to acquire smoking or drinking habits, with these protective eects
arising from specic biological dierences in nicotinic receptor function or alcohol
metabolism, respectively. These aversive eects can also be exploited therapeuti-
cally, as in widely available treatments for alcoholism and smoking. We and others
found that cocaine also produces aversive eects that can slow or block drug-seeking,
and that the magnitudes of these protective aversive eects also vary widely between
individuals. However, the molecular substrates of cocaine's aversive eects, and of
their variation between individuals, are almost entirely unknown. To examine these
substrates, we examined functions of the rostromedial tegmental nucleus (RMTg),
a major GABAergic input to midbrain dopamine neurons that plays key roles in
aversive learning from cocaine and other stimuli. In particular, we found that RMTg
neural activity is necessary for cocaine's conditioned aversive eects, and is correlated
with aversion magnitude. Furthermore, in collaboration with a slice electrophysiolo-
gist in the lab (Dr. Jerey Parrilla-Carrero), we identied several molecular drivers of
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this activity showing that cocaine drives RMTg activation via glutamatergic signal-
ing through calcium permeable AMPA receptors (CP-AMPARs) residing on RMTg
neurons. Additional data showed that this receptor undergoes dierential plasticity
in response to cocaine, as it is downregulated in low cocaine-avoider rats having es-
pecially low aversive responses to cocaine, relative to high cocaine avoider rats with
stronger aversive responses. We also showed that this modulation may be driven by
the phosphatase enzyme, PTEN, which has been previously implicated in synaptic
depotentiation. In particular, we found that inhibition of PTEN increases glutamate
signaling in RMTg and reduces cocaine-seeking, suggesting PTEN as a novel thera-
peutic target for cocaine addiction. Because RMTg neurons send strong inhibitory
projections to DA neurons in the ventral tegmetal area (VTA), which in turn project
to the nucleus accumbens (NAc), and because of extensive prior studies implicat-
ing D2 medium spiny neurons (D2 MSNs) in avoidance behavior, we also looked at
whether high- and low-avoiders have dierences in D2 MSNs properties of the nu-
cleus accumbens shell (NAshell) after exposure to cocaine. We found that aversion to
cocaine in high-avoiders correlated with increased neuronal excitability, enhanced glu-
tamate transmission and impaired long term depression (LTD) at excitatory synapse
in D2-MSNs of the NAshell, and demonstrated that RMTg plays a role in modulating




1.1 Operant Runway Model of Cocaine Seeking
1.1.1 Origins and Principles
Animal learning researchers have been using operant runways as a tool for the study
of goal-directed motivated behavior for several decades now [Miller, 1944, Crespi,
1942, Hull, 1934]. In such studies, the time required for the subject to traverse the
alley (i.e., Run Time) has proven to be a reliable proxy of the animal's motivation
to seek the incentive that has been paired with the goal box. Put simply, changes
in the subject's motivation to seek an incentive produce predictable and reliable
shifts in the run times required to get to the goal box. Thus the runway had some
potential as a means of measuring the motivation of animals to seek drugs of abuse.
Consequently, Ettenberg and his group designed and built a set of automated operant
runways which we adopted in our lab. In this apparatus, animals implanted with
intravenous catheters and connected to an elaborate drug delivery system, would
traverse a corridor and enter a goal box where they received an IV infusion of drug.
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Infrared photo-emitter/detector pairs planted throughout the entire runway deliver
signals to a desktop computer that controlled the hardware of the apparatus and
delivers the outputs, and recorded the positions of the animal in real time so that
Start Latency (time to leave the start box) and Run Time (time to enter goal box)
could be recorded, along with the precise trajectory that the rat took moving between
the two ends of the runway, on every trial.
Conceptually and procedurally, the approach is modeled on the classic runway
work of Crespi [Crespi, 1942] who showed that rats traversing an alley for food showed
Run Times that reected the magnitude of the reward (amount of food) delivered in
the goalbox. Additionally, Crespi observed that an unexpected sudden change in
the magnitude of the incentive delivered in the goal box resulted in a dramatic shift
in run latencies on the next trial (a phenomenon that has come to be known as
the Crespi eect). This suggested a way to experimentally dissociate the eect
of manipulations on motivational versus reinforcement processes. Conceptually, if an
experimental manipulation before a given trial altered the motivational capacity of the
animal, we expect to see an immediate eect on Run Time on that trial; conversely,
the reinforcing impact of actually earning the drug are reected by the changes in run
times from one trial to the next while having no impact on test day run times (since
the animal would not be aware of the change in reinforcer magnitude until after it
had entered the goal box). Therefore, the independent measure Run Times on any
given trial provides a good proxy of the animal's motivation to seek the reinforcer on
that trial, while changes in Run Times from one trial to the next reects the impact
of reinforcement on subsequent motivation, or the reinforcing consequences of earning
the drug.
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1.1.2 Runway Model and Drugs of Abuse
To date, runway self-administration has been established in rats working for a several
drug reinforcers including IV cocaine [Ben-Shahar et al., 2008, Deroche et al., 1999,
Ettenberg and Bernardi, 2006, Ettenberg and Geist, 1991, Ettenberg and Geist, 1993,
Heinrichs et al., 1998, Wakonigg et al., 2003], IV opiate receptor agonists such as
heroin, morphine, remifentanil and alfentanil [Crespo et al., 2006, Ettenberg et al.,
1996, McFarland and Ettenberg, 1995, Wakonigg et al., 2003], IV nicotine [Cohen and
Ettenberg, 2007], IV methylenedioxymethamphetamine (MDMA) [Wakonigg et al.,
2003], IV speedball (heroin+cocaine) [Guzman and Ettenberg, 2004], as well as
subcutaneous (SC) amphetamine [Ettenberg, 1990], SC morphine [Zernig et al., 2002],
oral ethanol [Czachowski, 1999], and both intracerebroventricular and intracranial
infusions of cocaine[Guzman and Ettenberg, 2007]. An early result of using this model
with cocaine was the unique behavioral aspect that the animals were exhibiting. In
previous studies using natural and drug reinforcers, the subjects run the alley faster
as trials progressed. In contrast, while cocaine-reinforced animals had normal start
latencies, they progressively slowed down on the runway over trials. Data from the
infrared emitter-detector pairs lining the base of the runway, allowed to distinguish if
those increases in latencies were not due to animals running more slowly, but rather
those animals showed more and more stop-and-retreat behavior as the experiment
progressed; animals would approach the goal box, stop, and then retreat back to the
start box [Ettenberg and Geist, 1991, Ettenberg and Geist, 1993, Jhou et al., 2013]
(Fig. 1.1).
These behaviors closely mimicked the classic approach-avoidance conict de-
scribed by Neal Miller [Miller, 1944] over 60 years ago in animals approaching a goal
box that had known mixed positive+negative characteristics like food+mild footshock
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Figure 1.1: A representative spatio-temporal record from a single trial of an experi-
enced animal running a straight alley once a day for IV cocaine. The record illustrates
the path that the subject took to reach to the goal box and earn the drug reinforcer.
The locations in the runway are represented by the numbers on the ordinate, with `1'
being an infrared sensor in the start box and 9 being one just outside the goal box
entry. Positions 1012 are inside the goal box. In the sample shown, the rat made
numerous approach avoidance `retreats' (stopping forward movement and returning
back toward the goal box) which are representative of mixed positive and negative
associations with the cocaine goal box. . Adapted from Ettenberg et. al, 2004.
[Geist and Ettenberg, 1997a]. To be clear, retreat behaviors are not strictly an index
for cocaine's negative or aversive eect but rather reect the existence of both positive
and negative associations with the goal box. Thus, the animals continue to return to
the goal area and eventually do enter and obtain their cocaine. Indeed, when the goal
box contains only negative stimuli (e.g., shock, or aversive drugs), the animals remain
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in the start box and choose not to go to the goal box at all. Consistent with this view
is the fact that the animals showing retreats in the corridor still developed positive
preference in a conditioned place preference test, suggesting that the cocaine has re-
tained its rewarding eects [Ettenberg and Geist, 1991]. It is also important to note
that the approach-avoidance retreat behaviors described above cannot be explained
by aversive properties of the goal box itself since a saline control did not produce
retreats [Ettenberg et al., 1996, Ettenberg and Geist, 1993]. It would thus seem then
that cocaine's biphasic actions (initial positive euphoric eect followed by a negative
dysphoric eect) together result in the animal's development of ambivalence about
entering the goal box. The runway model has thus proven to be sensitive to both
the positive (approach) and negative (avoidance) properties of the drug in the same
animal at the same time. It then represents a valuable means for studying the neu-
robiological basis of cocaine's two opposing drug actions that together undoubtedly
determine the nature of cocaine use and abuse (Fig. 1.2).
Figure 1.2: Operant runway model of cocaine self-administration.
Although the runway task is not as widely used as lever-pressing for cocaine self-
19
administration, we have chosen to study avoidance to cocaine for several reasons.
First, the single-trial nature of the runway task greatly helps to isolate the aversive
eects of cocaine, since the aversive responses are not masked by subsequent doses.
Moreover, unlike the lever-press procedure where animals work to maintain their
drugged state, the runway protocol assesses the motivation of undrugged animals to
return to a location (the goal box) where on previous trials cocaine had been deliv-
ered. Thus, by testing animals a single trial at a time, the procedure permits the
measurement of drug-seeking behavior independent of the potentially confounding
direct pharmacologic eects of the drug. So, for example, the increases in operant
running observed over trials cannot be easily accounted for by cocaine's psychomotor
stimulant properties nor by the potential development of drug-induced sensitization
since the animals' behavior was assessed prior to the delivery of the drug reinforcer.
Another advantage of the runway task is that the limited availability of cocaine more
closely resembles early drug use in humans, where users more commonly start with
individual trial doses rather than the more unbounded amounts available in con-
ventional self-administration paradigms at close to zero cost. Finally, Spealman's
[Spealman, 1979] classic nding that monkeys lever-pressing for cocaine on one lever,
would press a second lever in order to terminate drug availability suggest that both
measure of lever-pressing in self-administration and run times on the runway are, at
least partly, probing at similar underlying processes.
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1.2 The RMTg: the Anti-Dopamine Nucleus
1.2.1 RMTg Anatomy
The rostromedial tegmental nucleus (RMTg), is a GABAergic nucleus rst described
in 2009 as a major inhibitory input to neurons in the ventral tegmental area (VTA)
[Jhou et al., 2009a, Kauing et al., 2009]. This nucleus occupies a column of tissue
extending from the caudal edge of the VTA, to the rostral edge of the cholinergic neu-
rons of the pedunculopontine nuclei (PPTg). In the RMTg, GABAergic neurons are
embedded in the adjacent VTA, where they are close to the dopaminergic cellbodies
and dendrites; for this reason, the RMTg is also called `tail of the VTA' or `retro
VTA' [Scammell et al., 2000, Perrotti et al., 2005, Olson and Nestler, 2007, Brin-
schwitz et al., 2010].
RMTg eerents project densely to midbrain regions where dopamine (DA) neu-
rons are found [Jhou et al., 2009a], and overwhelmingly make inhibitory-type synapse
on tyrosine hydroxylase (TH)-positive neurons in the VTA and substantia nigra. The
projections from the RMTg to the DArgic nuclei have been extensively character-
ized by tracing and electron microscopy studies and they show a topographical or-
ganization: the rostro-medial RMTg sends denser projection to the VTA, while the
latero-caudal RMTg to the SNpc.
The RMTg also sends abundant local projections to the brainstem regions impor-
tant in the control of motivation, stress, attention and arousal (VTA, SNpc, RRF,
dorsal raphe, pedunculopontinetegmental nucleus, locus coeruleus and subcoeruleus,
Barringtonnucleus)[Jhou et al., 2009b, Lavezzi and Zahm, 2011, Sego et al., 2014].
The RMTg receives dense excitatory glutamatergic inputs form the LHb, a nu-
cleus involved in aversive event signaling and decision making [Hikosaka, 2010, Proulx
et al., 2014], and the density of the projection from LHb to the RMTg is greater than
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Figure 1.3: Connections of excitatory and inhibitory neurons associated with the
dopaminergic nuclei. Adapted from Morello et. al, 2015.
other more familiar projection such as the VTA, interpeduncular nucleus, median
and paramedian raphe and laterodorsal tegmental region [Jhou et al., 2009c, Kau-
ing et al., 2009]. LHb projections to RMTg are organized in a highly topographic
manner. Tracing studies show that habenula projections are also topographically
organized, where medial LHb regions project to the median and paramedian tegmen-
tum and involve only the most medial and rostral part of the RMTg, and lateral LHb
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projects proportionately to more lateral and caudal parts of the RMTg, [Jhou et al.,
2009b], that in turn more strongly innervate the VTA and SNpc, respectively (Fig.
1.3) [Jhou et al., 2009b, Gonçalves et al., 2012, Yetniko et al., 2015]. Interestingly,
this lateral part of the LHb receives its strong input from the ventral pallidum (VP)
and entopeduncular nucleus (EPN) [Herkenham and Nauta, 1977], which suggests
that a trans-habenula inuence of the ventral and dorsal parts of the basal ganglia,
respectively, are delivered to the RMTg, via the projection from the LHb. Thus,
the RMTg acts as an intermediate target between the LHb and the VTA, converting
the excitatory stimuli from the LHb to inhibition of the DArgic neurons. Numer-
ous other forebrain and brainstem structures also project varyingly strongly to the
RMTg, including structures implicated in aversive processing such as the anterior
cingulate cortex [Vogt, 2005] and subcortical regions such as the septum [Sheehan
et al., 2004], parts of the extended amygdala [Davis et al., 2010], and the periaque-
ductal gray [McNally et al., 2011]. Inputs also arise from the medullary, pontine,
and mesencephalic reticular formation, parabrachial nucleus, laterodorsal and pedun-
culopontine tegmental nuclei, dorsal raphe, intermediate layers of the contralateral
superior colliculus, substantia nigra, lateral habenula (lHb), zona incerta, lateral and
dorsal hypothalamic areas, preoptic region, parts of the extended amygdala (with the
notable exception of the central nucleus of the amygdala), ventral striatopallidum,
and frontal cortex [Kauing et al., 2009, Jhou et al., 2009c, Lavezzi and Zahm, 2011]
(Fig. 1.4).
1.2.2 Cellular Prole
Morphological analysis of the RMTg reveals that this structure is a heterogeneous pop-
ulation of cells comprised of small and medium-sized neurons [Jhou et al., 2009b]. The
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Figure 1.4: This schematic illustrates some of the major tVTA inputs andoutputs. (A)
RMTg aerents are widely dispersed and originate from abroad range of structures
within the forebrain, diencephalon, midbrain and brainstem. (B) RMTg eerents pref-
erentially target dopaminergic neurons of the VTA/SNc complex and neurons of the
LH. Abbreviations: BNST, bed nucleus of the stria terminalis; Cg, cingulate cortex;
CPu, caudate putamen; DMTg, dorsomedial tegmental area; DP, dorsal peduncular
cortex; DR, dorsal raphe; IL; infralimbic cortex; IPN, interpeduncular nucleus; LC,
locus coeruleus; LH, lateral hypothalamus; LHb, lateral habenula; LPOA, lateral pre-
optic area; LDTg, laterodorsal tegmental nucleus; MR, median raphe; NAc, nucleus
accumbens; Pa, parafascicular thalamic nucleus; PAG, periaqueductal gray; PMnR,
paramedian raphe nucleus; Pn, pontine reticular nucleus; PPTg, pedunculopontine
tegmental nucleus; PrL, Prelimbic cortex; RN, red nucleus; RRF, retrorubral eld;
SC, superior colliculus; SI, substantia innominate; SNc, substantia nigra pars com-
pacta; VP, ventral pallidum; VTA, ventral tegmental area; ZI, zona incerta. Adapted
from Fakhoury et. al, 2018.
vast majority of these neurons ( 7092 %) are GABAergic [Jhou et al., 2009b, Kau-
ing et al., 2009] and expressed Fos in response to several aversive stimuli [Jhou
et al., 2009a] and psychostimulants [Perrotti et al., 2005, Kauing et al., 2009, Kau-
ing et al., 2010]. With some heterogeneity, RMTg neurons are also enriched in opioid
receptor, somatostatin and prepronociceptin [Jhou et al., 2009a]. More recently, a ge-
netic marker of the RMTg, the transcription factor FoxP1 , has been identied both
in mice [Lahti et al., 2016] and rats [Smith et al., 2019a], and has been shown to
be selectively expressed in the RMTg relative to surrounding areas such as the VTA
(Fig. 1.5).
In vivo, the mean ring rate of RMTg neurons is between 11 and 18 Hz, the
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Figure 1.5: Distribution of FoxP1 neurons across the rostrocaudal axis of the ven-
tral midbrain, as compared to the distribution of dopamine (TH-expressing) and
PPTg acetylcholine (NOS-expressing) neurons in rats. Graph shows number of neu-
rons immunoreactive for FoxP1, TH, and NOS in 40-um coronal sections at specic
anterior-posterior (AP) distances based on the rostral edge of the interpeduncular
nucleus (IPN). Adapted from Smith et. al, 2019.
interspike interval is around 73 ms, and the mean duration of their action poten-
tial measured from peak to trough is roughly 1 ms [Jhou et al., 2009a, Jalabert
et al., 2011, Lecca et al., 2011]. In vitro, RMTg neurons re slower ( 5 Hz), and
the excitatory postsynaptic currents (EPSCs) evoked in this region are a result of
the presence of amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors
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on RMTg neurons [Lecca et al., 2011].
1.2.3 Distinction Between RMTg and GABA Neurons of the
VTA
Although some studies have shown similar functions between RMTg and VTA GABA
neurons, for example that they have similar inhibitory inuences on DA neurons in
mediating reward prediction errors [Hong et al., 2011, Jhou et al., 2009a, Stopper
et al., 2014, Eshel et al., 2015], and that activation of either RMTg or VTA GABAer-
gic neurons induce behavioral avoidance [Jhou et al., 2009a, Lammel et al., 2012, Tan
et al., 2012, Stamatakis and Stuber, 2012], several lines of evidence suggest a dis-
tinct function of these two populations. For example, mu opioid agonists are more
reinforcing when infused into the RMTg compared to VTA, and agonists of these
receptors block inhibition of DA neurons induced by stimulation of the RMTg but
not VTA interneurons [Jalabert et al., 2011, Matsui and Williams, 2011, Jhou et al.,
2012, Matsui et al., 2014, Zangen et al., 2002].
Moreoever, to address the physiological dierences between RMTg and VTA
GABAergic neurons, a series of studies from Uchida's group have recorded geneti-
cally identied GABAergic neurons in the VTA and showed that they display ramping
activities in responses to reward cues and that they remain activated until animals
receive rewards [Cohen et al., 2012, Eshel et al., 2015], contrasting with RMTg neu-
rons that were inhibited by reward cues and then quickly returned to baseline ring
levels. Moreover, optogenetic inhibition of VTA GABA interneurons disrupts phasic
DA responses to reward cues and results in a sustained DA activation throughout
the entire presence of cues [Eshel et al., 2015], whereas RMTg lesions removed most
of the aversion-induced inhibition in VTA neurons without aecting the proportion
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or responses of VTA neurons to reward cues [Li et al., 2019b]. RMTg neurons also
predominantly show negative valence encoding (i.e. activation by aversive stimuli and
inhibition by reward-predictive cues) which is not described in VTA neurons. Finally,
RMTg neurons are enriched in Pnoc and FoxP1, whereas the majority of GABAergic
neurons in the VTA lack those markers [Smith et al., 2019b].
Taken together, these results suggest that RMTg does not appear to be simply
a caudal extension of VTA GABAergic neurons, and conveys dierent information
onto DA neurons than VTA GABAergic neurons, while potentially mediating distinct
aspects of motivated behaviors.
1.2.4 RMTg Function
Several studies have suggested an important RMTg role in conveying information
about aversive stimuli onto VTA and substantia nigra DA neurons and mediating be-
havioral responses to these aversive stimuli [Hong et al., 2011, Jhou et al., 2009a, Jhou
et al., 2013, Vento et al., 2017, Brown et al., 2017]. In fact, RMTg neurons are inhib-
ited by rewards and reward-predictive stimuli, and activated by aversive stimuli and
their predictors, as well as unexpected omission of reward [Hong et al., 2011, Jhou
et al., 2009a, Li et al., 2019a], opposing VTA DA neurons but mimicking lHb glu-
tamatergic neurons [Matsumoto and Hikosaka, 2007, Cohen et al., 2012, Jhou et al.,
2009a]. These response patterns are consistent with the RMTg playing roles in loco-
motor inhibition and aversion learning, which appear to oppose DA roles in locomotor
activation and reward learning. Indeed, evidence strongly suggests that the RMTg
plays a critical role in aversive processing and mediates aversive behaviors through its
inhibitory projections to VTA DA neurons. Our lab and others have demonstrated
that RMTg neurons are activated by several aversive stimuli of widely varying sen-
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sory modalities and timescales, including footshock, loud siren, bright light, lihium
chloride, retraint stress and cocaine. RMTg drove VTA inhibitions [Balcita-Pedicino
et al., 2011, Bourdy et al., 2014], and conditioned place aversion (CPA) to these aver-
sive stimuli, without aecting VTA activation or CPP to rewarding stimuli [Li et al.,
2019a]. Moreover, lesions of the RMTg were shown to decrease open arm avoidance
on an elevated plus maze, suggesting a potential role for the RMTg in anxiety-like
behavior [Jhou et al., 2009a].
In addition to motivated behavior, the RMTg regulates motor activity trough
the inhibition of the SNpc and subsequent reduction of DA release in the dorsal
striatum [Bourdy et al., 2014]. Consistent with this, lesioning of the RMTg resulted
in disinhibition of the DArgic system, increased DA in the dorsal striatum and motor
excitation.
Combining its role in motivated behavior and locomotion, the RMTg seems to
play a strong role in promoting inhibitory avoidance behaviors in response to aversive
stimuli [Jhou et al., 2009a]. Indeed, activation or inhibition of the RMTg to VTA
pathway produces conditioned place avoidance and preference, respectively [Smith
et al., 2019a]. Furthermore, lesion or inactivation of RMTg neurons are found to
reduce many aversive behaviors including conditioned place avoidance, fear-induced
freezing behavior, nociceptive response, punishment resistance, acute and chronic
withdrawal from abused drugs [Jhou et al., 2009a, Jhou et al., 2013, Jhou et al.,
2012, Smith et al., 2019a, Vento et al., 2017, Elmer et al., 2019, Greco et al., 2008,
Kauing and Aston-Jones, 2015], while sparing active fear responses. For instance,
excitotoxic lesions or optogenetic inactivation of the RMTg at a period when cocaine
exhibits aversive eects abolish cocaine induced avoidance behaviors in a runway
operant paradigm [Jhou et al., 2013], whereas optogenetic activation of LHb inputs
to the RMTg increases behavioral avoidance and decreases positive reinforcement in
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mice [Stamatakis and Stuber, 2012]. These ndings lead to speculation that the
RMTg is involved in conveying information about negative reward signals and as a
result leading to behavioral inhibitory responses.
Therefore, the RMTg is implicated together with the VTA in behavioral respond-
ing to reward omission, aversive stimuli, fear-eliciting stimuli, and withdrawal from
drugs of abuse [Jhou et al., 2009a, Jhou et al., 2013, Hong et al., 2011, Lecca et al.,
2011, Lecca et al., 2012, Matsui and Williams, 2011, Glover et al., 2016, Fu et al.,
2016, Wasserman et al., 2013] and with the SNc in motor skill and motor learning
[Bourdy et al., 2014, Lavezzi et al., 2015]. It thus conveys information regarding the
aversive qualities of stimuli to DA neurons [Ungless et al., 2004, Brischoux et al.,
2009]. RMTg's response to aversive stimuli or the cue associated to that stimlus, and
the resulting inhibition of DA cells may be pivotal in promoting avoidance learning.
Indeed, this circuit could provide an aversive teaching signal that punishes actions
occurring in the recent past, and its responses to cues may inhibit the ongoing seek-
ing of rewards to be obtained in the immediate future [Vento et al., 2017]. We can
thus think of the RMTg as a converging nucleus, integrating multimodal internal and
external information, and conveys the output to DA neurons of VTA and SNc to
modulate motor/motivational responses.
1.3 Aversive Properties of Drugs of Abuse
1.3.1 Opponent Process Theory and Cocaine
Human users of cocaine describe two distinct aective consequences of drug adminis-
tration: an initial and profound euphoria usually followed by a dysphoric state char-
acterized by anxiety, fatigue, agitation, depression, and oftentimes cravings for more
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cocaine [Kampman et al., 1998, Anthony et al., 1989, Mulvaney et al., 1999, Resnick
et al., 1977a, Rohsenow et al., 2007, Spotts and Shontz, 1984, Williamson et al.,
1996a]. Clinical studies report that the negative properties of the drug can even
precipitate episodes of panic attack and other related anxiogenic states [Cox et al.,
1990, Geracioti and Post, 1991, Goodwin et al., 2002, Walsh et al., 1990]. These
aversive eects may strongly modulate drug-seeking, and are observed in almost all
drugs of abuse, including psychostimulants, opioids, nicotine, and alcohol [Solomon
and Corbit, 1974, Koob et al., 1989, Panlilio et al., 1996, Ettenberg et al., 1999, Kenny
and Markou, 2001, Rothwell et al., 2009, Riley, 2011]. The mechanisms of the aver-
sive eects have been thought to result from opponent processes where aversive
eects work against, and outlast, the initial rewarding eects (Fig. 1.6) [Solomon
and Corbit, 1974].
The notion that cocaine has negative or aversive side eects has also been sug-
gested by the results of animal research studies using diverse paradigms such as CPP
and CPA, [Ettenberg and Bernardi, 2007, Ettenberg et al., 1999], CTA [Verendeev
and Riley, 2012], and operant paradigms [Ettenberg, 2009, Rezvani et al., 2010, Bar-
rot et al., 2012]. For example, over two decades ago, [Spealman, 1979] reported that
monkeys trained to lever-press for intravenous cocaine would also choose to press
a second lever that terminated drug availability. In more recent studies, cocaine
has been observed to decrease punished responding in a rodent conict test[Fontana
and Commissaris, 1989], to have anxiogenic eects [Prather and Lal, 1992], induce
anxiogenic-patterns of exploratory behavior in the elevated plus-maze [Rogerio and
Takahashi, 1992], to increase animals' latency to enter an open eld [Yang et al., 1992],
and to increase latencies to reach a cocaine-paired goalbox in an operant runway task
[Ettenberg and Geist, 1993].
We now know that cocaine's motivational properties are biphasic, with rewarding
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Figure 1.6: A schematic representation of the aective response to an injection of
cocaine as predicted from Opponent Process Theory. Following administration there
is an initial positive reaction that rises quickly to a short-lived peak level (time point
`A'), and then decreases to a steady state level that eventually gives way and drops
back toward initial baseline (neutral) levels. The delayed onset of a second opposing
negative/aversive state is in part responsible for the reduction in positive aect and
in time exerts a net negative impact on the subject's aective experience (time point
`B'). Adapted from Ettenberg et. al, 2004.
eects most prominent within the rst 10 minutes after individual intravenous (iv)
infusions, while aversive properties are prominent slightly later, beginning roughly 15
minutes post-infusion, suggesting that drugs of abuse are complex pharmacological
compounds with multiple stimulus eects and both the rewarding and the aversive
eects of drugs should be taken into consideration in ongoing attempts to model
drug-taking behavior.
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1.3.2 RMTg and Aversion
Recent studies have identied cocaine-induced activation of a dense, previously over-
looked GABAergic input to midbrain DA neurons arising from the RMTg. A number
of studies have implicated the RMTg in processing the aversive properties of drugs of
abuse including psychostimulants [Kauing et al., 2009, Kauing et al., 2010, Jhou
et al., 2009a, Jhou et al., 2013, Zahm et al., 2010], opiates [Lecca et al., 2011, Lecca
et al., 2012, Matsui and Williams, 2011] and alcohol [Glover et al., 2016, Fu et al.,
2016]. This activation has been demonstrated both through cfos induction [Kauing
et al., 2010] as well as phasic activations [Lecca et al., 2011, Li et al., 2019a] to acute
exposure to a variety of drugs of abuse. Specically, RMTg has been shown to have a
biphasic response after an acute dose of cocaine, with an initial inhibition followed by
delayed excitation paralleling cocaine's shift from rewarding to aversive. Moreover,
stimulation of either the LHb or RMTg inhibits 8297 % of DA neurons [Hong et al.,
2011, Christoph et al., 1986, Ji and Shepard, 2007, Matsumoto and Hikosaka, 2007]
and contributes to aversive conditioning [Lammel et al., 2012, Stamatakis and Stu-
ber, 2012]. Indeed, direct activation of the RMTg (by AMPA) is sucient to produce
aversive conditioning, while cocaine-conditioned avoidance responses are abolished
by lesions of the FR or RMTg, or by inhibition of RMTg activity 1525min after
cocaine delivery [Jhou et al., 2013]. However, despite these studies, RMTg's molecu-
lar substrates of cocaine's aversive eects, and of their variation between individuals,
are almost entirely unknown, and a better understanding of the role of RMTg in
modulating drug aversion's role in drug-taking is crucial for nding new avenues for
interventions.
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1.3.3 Accumbens and Aversion
The mesolimbic DArgic system not only plays a pivotal role in a wide range of mo-
tivation and learning [Wise, 2004, Schultz, 2007, Bromberg-Martin et al., 2010], but
its dysfunction has also been implicated in severe neuropsychiatric disorders, and
has been widely implicated in modulating drug addiction. DA neurons in the VTA
react to rewarding stimuli by phasic ring, and the main function of this ring is
suggested to encode reward prediction error, [Schultz et al., 1997]. In contrast to the
response to rewarding stimuli, DA neurons' response to aversive stimuli are far from
homogeneous; i.e., some DA neurons are activated in response to aversive stimuli,
whereas most others react by decreasing their rings [Cohen et al., 2012, Ungless
et al., 2004, Brischoux et al., 2009, Matsumoto and Hikosaka, 2009]. In fact, recent
studies have revealed that optogenetic activation of GABAergic neurons and resultant
inactivation of DA neurons suppresses reward consumption and induce an aversive
response [Tan et al., 2012, van Zessen et al., 2012]. However, it has largely remained
elusive as to which mechanisms in the neural circuits are essential for the acquisition
of aversive learning following the inactivation of DA neurons in the VTA and as to
how behavioral responses are controlled toward suppressing reward consumption and
inducing aversive behaviors. The general understanding is that DA signals from the
midbrain dynamically modulate the direct and indirect pathways in opposite direc-
tions via Dopamine D1 receptor (D1Rs) and Dopamine D2 receptor (D2Rs), and this
modulation is supposed to facilitate motivational learning [Bromberg-Martin et al.,
2010, Surmeier et al., 2009]. As for the rewarding stimuli, up-regulated DA levels
induced by rewarding signals activate the D1Rs and thus excite the direct pathway
in the nucleus accumbens (NAc). On the other hand, the suppression of DA neuron
rings in response to aversive stimuli decreases DA levels in the NAc which results
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in increase of signal transmission in the indirect pathway through activated D2Rs.
And while VTA DA neurons project to multiple brain areas, the most prominent
pathway involved in this bidirectional encoding of reward and aversive stimuli is be-
lieved to be encoded in the ventral striatum. For example, a recent elegant study
by Roitman et al. stimulated a sensory pathway that can carry both positive and
negative information to show that opposite dopamine state in the NAshell is key
for encoding opposing valences stimuli. Particularly, Roitman et al., demonstrated
that sucrose rewards increase, while the aversive quinine suppressed the frequency of
dopamine transients in the NAshell [Roitman et al., 2008]. Several studies using the
pharmacological strategies and reversible neurotransmission blocking (RNB) method
have supported this mechanism of regulation in the NAc [Hikida et al., 2010, Hikida
et al., 2013], and it has been shown that this aversive learning is mediated through
D2. One study in particular showed that selective optogenetic inactivation of DA
neurons in the VTA decreased DA levels in the NAc which induced aversive reaction
and learning through D2 activation [Danjo et al., 2014]. Interestingly the optoge-
netic up-regulation of D2R-expressing medium spiny neurons (MSNs) in the indirect
pathway in the NAshell evokes behavioral avoidance [Kravitz et al., 2012]. To ex-
tend those ndings to cocaine, acute cessation of cocaine intake causes accumbens
DA levels to fall below baseline [Panlilio et al., 1996] and decreased 3040 % during
cocaine withdrawal compared with pre-session levels, whereas reduced accumbens DA
signaling in turn produces CPA [Shippenberg et al., 1991]. But despite this observa-
tion, it is still not clear whether the bi-directional encoding of reward and aversive
behavioral response in the NAshell is true for cocaine, and what are the implications
for D2 MSNs, and to what extent the dierences in this process correlate with indi-
vidual dierences in cocaine avoidance. The fact that the NAc also plays a role in
aversion seems to still be underappreciate and requires extensive studies for a more
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comprehensive understanding of the circuitry of aversion.
1.3.4 Implications in Addiction
Over 90 of Americans have had some exposure to drugs of abuse, but only 15-32 of
individuals exposed to the major classes of abused drugs (nicotine, alcohol, cocaine,
heroin) go on to become addicted, with the rest presumably being able to stop on
their own, before progressing to addiction [Wagner-Echeagaray et al., 1994, Wenzel
et al., 2011, Heyman, 2013], suggesting that not all individuals are equally vulnerable
to developing addiction-like behavior [Deroche-Gamonet and Piazza, 2014]. How-
ever, little is known about the neurobiological predisposing factors regulating the
propensity toward addiction. Indeed, the reasons for these individual dierences are
complex and likely involve multiple areas of vulnerability. Some such areas of dif-
ferential vulnerability could involve dierences in initial responses to drugs. In fact
much basic research has been directed at understanding individual animals who have
already progressed into addiction-like behaviors, with relatively less study of what
protective factors may help prevent acquisition or escalation of drug use in the rst
place and hence render some individuals less vulnerable to becoming addicted, one
of those factors being drug-induced aversion. Even after relatively infrequent admin-
istration of cocaine, aversive responses are powerful enough to greatly attenuate or
prevent seeking of drugs or drug cues. These responses have been posited to ex-
plain why many humans and rodents do not progress from occasional to compulsive
drug use despite the drug's strong rewarding properties [Deroche-Gamonet et al.,
2004, Wagner-Echeagaray et al., 1994]. Seminal studies from Dr. Ettenberg and
colleagues have identied key attributes of cocaine's aversive properties that are suf-
cient to condition a net aversion to cocaine, that in most (but not all) animals, is
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strong enough to overcome cocaine's rewarding eects [Ettenberg et al., 1999, Et-
tenberg, 2004, Jhou et al., 2013, Ettenberg and Bernardi, 2007]. These individual
dierences in aversive responses to drugs may contribute to dierences in individual
propensity to develop addictive behaviors. For example, high aversive responses to
drugs may be protective against early acquisition of drug-seeking as individuals seek
to avoid drug-induced aversion, and the underlying mechanism can be exploited to
better understand why some individuals are protected whereas others are not.
Although aversion confers a protective eects initially, it is likely to promote drug-
seeking in later stages, as individuals seek to mitigate the aversive eects of recent
drug use. Indeed, it has been posited that withdrawal play an important role in the
transition of drug use to the development of dependence. Indeed, some have gone so
far as to argue that the presence of a negative aective state is the dening feature
of addiction [Koob and Le Moal, 2005, Russell, 1976, Baker, 1987], where those
begative states might substantially contribute to the maintenance of dependence.
The motivation for maintenance of compulsive drug use could now be thought of
requiring both negative reinforcement processes and positive reinforcement processes
where the individual is seeking the drug not only to retrieve the rewarding eect, but
also to alleviate the aversive state. Therefore, understanding the mechanisms behind
drug aversion, and the role it plays a dierent stages, could help provide dierent
interventions depending on the stage that is being targeted.
1.4 Statement of the Problem
Cocaine addiction is a devastating brain disorder that aects the health of millions
of people in Western countries and is associated with high health-care costs [Uhl
and Grow, 2004]. Despite the substantial sum of money spent on treatments for
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substance use disorder, eect sizes of all available therapies oered are typically mod-
est with a substantial proportion of patients failing to respond. Psychostimulant in
particular, including cocaine, addiction treatment is dicult because of the lack of
ecient medication and other therapies [Jupp and Lawrence, 2010]. Because there
are large individual dierences in vulnerability to cocaine addiction, novel insights
into possible mechanisms and treatments may arise from studying individuals that
are naturally resilient to cocaine-taking, but the precise dierences in these individ-
uals has not yet been uncovered. Despite the striking inuence of drug aversion on
behavior, little is known about its neural mechanisms nor whether these mechanisms
can be targeted for therapeutic eect, and this topic as a whole remains relatively un-
derstudied. Elucidation of factors underlying inter-individual dierences in substance
use behavior, specically aversive eects of drugs, could result in the individualiza-
tion of therapies and targeting of specic clusters of patients using psychotherapeutic
or pharmacological approaches, which include the prediction of therapeutic response
based on pharmacogenetic proles. In this study, I will examine individual dierences
in cocaine aversion and its role in cocaine addiction vulnerability at three levels: 1)
behavioral; 2) circuitry; 3) molecular.
Particularly, I hypothesize that RMTg neurons in "low- cocaine avoiders" exhibit-
ing weak aversive responses to cocaine will be less excitable during the aversive phase
of cocaine compared to "high-cocaine avoiders" who exhibit strong aversive responses
to cocaine. The resulting dierence in RMTg-mediated inhibition of DA neurons be-
tween the two populations will in turn result in dierential adaptations in D2-MSNs
in the NAshell, which will lead to opposite behavioral outputs towards drug-seeking.
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2.1 Animals and Surgeries
2.1.1 Animals
Adult male Sprague Dawley (Charles River Laboratories, Raleigh, NC, USA), weigh-
ing 250300g upon delivery from vendor (Charles River Laboratories, Raleigh, NC,
USA; ), were individually housed in standard ventilated shoebox cages within a
temperature-controlled (22 ◦C), 12/12 h light/dark cycle (lights on at 6:00am) vi-
varium, with food and water provided ad libitum, unless otherwise stated. Proce-
dures conformed to the National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and all protocols were approved by Medical University of South
Carolina Institutional Animal Care and Use Committee. All animals were tested
during the light phase.
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2.1.2 Catheter Surgeries
Rats were anesthetized with isourane and tted with indwelling intravenous catheters
inserted into the right jugular vein, and subcutaneously passed to a guide cannula
exiting the animal's back. After surgery, catheter patency was maintained via daily
ushing with 0.05 ml of Taurolidine Citrate Solution. Animals recovered for 7 days
prior to behavioral testing. Catheter patency was assessed periodically through obser-
vation of the loss of the righting reex after i.v. injection of, methohexital (Brevital,
2.0 mg/kg/0.1 ml). Rats that were unresponsive to Brevital were implanted with a
new catheter using the left jugular vein.
2.1.3 Stereotaxic Surgeries
Dlight: Stereotaxic viral vector injections were performed in mice anesthetized with
isourane (13 % in 95 % O2/5 % CO2 provided via nose cone at 1 L/min) as previ-
ously described (Cho et al., 2017). Following anesthesia, preparation and sterilization
of the scalp, and exposure of the skull surface, a craniotomy hole was drilled over the
LNAc (antero-posterior: 1.2 mm, medio-lateral: 1.6 mm relative to Bregma). 800 nL
of the AAV9-hSyn-dLight1.2 vector (titer: 4 x 1012 viral genomes/mL, produced at
the UC Davis Vision Center Vector Design and Packaging Core facility; Addgene #
111068) was delivered into the NAshell (antero-posterior: 1.8 mm, medio-lateral: 0.8
mm, dorso-ventral: 7.2 mm relative to Bregma) using a blunt 33-gauge microinjec-
tion needle within a 10 mL microsyringe (NanoFil, World Precision Instruments), a
WPI microsyringe pump (UMP3, World Precision Instruments), and pump controller
(Micro4, World Precision Instruments) over 10 min. Following viral injection, a 5 mm
long, 400 mm outer diameter mono ber-optic cannula (Doric Lenses Inc) was low-
ered to the same stereotaxic coordinates and axed to the skull surface with C and
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B Metabond (Parkel Inc) and dental cement.
Electrode implants: For recording experiments, drivable electrode arrays were
implanted above the RMTg (AP: -7.4mm; ML: 2.1mm; DV: -7.4mm from dura, 10-
degree angle).
Cannula implants: A doubled 6mm length guide cannula (Plastic One Inc.) was
implanted in RMTg (AP: -7.4mm; ML: 2.1mm; DV: -7.4mm, from dura, 10-degree
angle) or in NAshell (AP: 1.8mm; ML: 2.3mm; DV: -8mm, from dura, 10-degree
angle).
2.2 Behaviors
2.2.1 Runway Operant Cocaine-Seeking
Methods are similar to our previous work [Jhou et al., 2013]. Briey, the run-
way consists of two opaque plastic compartments (start and goal, 25x10x17 cm
length/width/height) connected by a 170cm long corridor with motorized doors be-
tween the start/goal boxes and corridor. Rats are tethered to an intravenous line,
then placed into the start box for 30 seconds, after which doors are opened and allow-
ing free exploration of the apparatus. Entry into the goal box causes doors to close
and a syringe pump to deliver cocaine (0.75mg/kg iv over 10 seconds, same dose as
in CPP and electrophysiological recording). Failure to enter the goal compartment
after 15 minutes results in a timeout. 7 trials are given, at most twice daily and at
least 4 hours apart, ensuring that animals run in a cocaine-free state, during the light
cycle over a period of 4-5days. All animals are habituated to the runway apparatus
before starting cocaine trials; all animals must have at least 2 consecutive habitua-
tion sessions under with run latency<60s before progressing to cocaine 1 session. the
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criterion for a retreat was a reversal in direction for a distance spanning a minimum
of two photobeams.
2.2.2 Progressive Ratio and Punishment Resistance
Training procedures are identical to those we previously described [Vento et al., 2017].
Briey, animals are food restricted to 85 of initial body weight, trained to leverpress
for food pellets (45mg) until stable response rates were reached, then tested either on
the PR task with progressively increasing eort requirements (leverpresses required
per pellet) [Richardson and Roberts, 1996] or progressively increasing punishment
(i.e. a footshock of increasing intensity presented 1 second after food pellet delivery,
whose magnitude increases about 25 every 3 trials). In the PR task, rats time out
if two minutes passed without a leverpress. In the punishment task, a timeout is
dened by 3 consecutive trials with >30 seconds passing without a leverpress. For
both tasks, the breakpoint is the last successfully completed ratio or shock intensity
endured before timeout.
2.2.3 Novelty-Induced Locomotion
Novelty-induced locomotion was recorded in operant chambers placed inside sound-
attenuating cabinets Movement within the chamber were detected via interruptions
of an array of 4 photodetector/emitter pairs. Locomotor counts were averaged over
two sessions on consecutive days, lasted for 30 minutes each.
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2.2.4 Conditioned Place Preference/Conditioned Place Aver-
sion
CPP/CPA was assessed using an unbiased protocol. We used a 3-chambered appa-
ratus with two conditioning chambers (having dark versus light colored walls) and a
small neutral center chamber. On day 1, animals were placed in the central chamber
and a baseline was collected for 15 min. Animals received a total of four conditioning
sessions for each task. Rats received an infusion of i.v. cocaine (0.75 mg/kg) on
the paired side (0 min post-infusion for CPP and 15 min post-infusion for CPA) or
Lithium Chloride (0 min post-infusion only) and saline on the unpaired trials (left for
15 min in the chamber). Two session were conducted daily (cocaine/LiCl and saline)
counterbalanced in both order of test (CPP vs CPA) and identity of the drug-paired
chamber (dark versus light walls). One day after nal conditioning sessions, animals
were tested by placement into the central compartment of the CPP apparatus for 15
min, and time spent in each compartment was recorded.
2.2.5 Shuttlebox Shock Escape
Rats were placed into a shuttlebox having two equal sized compartments and a mo-
torized doorway connecting the two. At two-minute intervals, footshock was delivered
via a oor grid, which terminated after the rat crossed through the doorway. Pho-
tobeams measured the latency to reach the other side. 10 trials were given for each
session, and average latency recorded for each rat. Shock intensity was xed during
each session, and two sessions were conducted for each rat at each shock intensity.




After being tested on the runway task, animals were trained on a daily 2h session of
cocaine self-administration during the light cycle, in standard Med Associates operant
chambers equipped with two levers, a house light, cue light, and tone generator.
The designated active lever delivered an infusion of cocaine (0.75 mg/kg/infusion)
dissolved in sterile 0.9 saline, along with a compound cue (light + tone) on an FR1
schedule of reinforcement. Following each infusion, a 20 s time out was signaled by
the loss of illumination of the house light where active lever presses resulted in no
programmed consequence. Responses on the inactive lever were recorded but had no
programmed consequence. Two days prior to the start of training, rats were food-
restricted to 15 g of chow per day to facilitate acquisition of SA. All rats received
ad libitum access to food once SA training was done. During self-administration
training, for rats that did not spontaneously acquire lever-pressing within 3 sessions,
the active lever was baited with a chow food pellet. Once rats reached stability (10
or more infusions) foo baiting was discontinued. After a minimum of 10 days of self-
administration >15 infusions, including the last 3 days, and discrimination between
the active and inactive levers, animals moved into extinction. During extinction
training, rats were exposed to the SA environment for a 2-h session each day across
10 consecutive days. During the extinction sessions, lever presses had no scheduled
consequences; ie no longer produced drug or presentation of the drug-paired cues. and
the responses on the active and inactive levers were recorded. Rats received extinction
training on a minimum of 7-8 consecutive days until the responding on the active
lever fell to <10 of the active lever pressing during maintenance for 3 consecutive
days. The day after achieving this criterion, subjects were returned to the operant
chambers for reinstatement testing. Reinstatement testing began following extinction
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training. For cue reinstatement, active lever presses resulted in the presentation of
the cues (both tone and light), but no cocaine infusions. For cocaine reinstatement,
rats received a systemic cocaine injection (10 mg/kg, ip) and were immediately placed
in the chambers. Cocaine-seeking behavior was operationally dened as responses on
the active lever in the absence of cocaine reinforcement [Beardsley and Shelton, 2012].
2.2.7 Elevated Plus Maze
The maze consisted of two open (50 x 20 cm) and two enclosed arms (50 x 20 x 30
cm) and an open roof with the entire maze elevated 100 cm from the oor. Each rat
was initially placed in the center of EPM (facing toward open arm) to explore freely.
Rats' behavior was recorded for 3 min by a video camera mounted centrally above the
maze. The time spent in open vs closed arms of the maze was recorded and reported
by a blind experimenter.
2.2.8 Pavlovian Training
Behavior was conducted in standard Med Associates chambers (St. Albans, VT).
Food-predictive and neutral cues were a 1 kHz tone (75 dB) and white noise (75dB),
respectively. The food-predictive cue was presented for 2s, and a food pellet (45
mg, BioServ) was delivered immediately after cue oset. The neutral cue was also
presented for 2s, but no food pellet was delivered. The two trial types were randomly
presented with a 30s interval between successive trials. A correct response was
scored if the animal either entered the food tray within 2 s after reward cues or
withheld a response for 2 s after neutral cues. Rats were trained with 100 trials per
session, one session per day, until they achieved 85 % accuracy in any 20-trial block,
after which animals were then trained with one extra session in which neutral cue
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Electrodes consisted of a bundle of sixteen 18 um Formvar-insulated nichrome wires
(A-M system) attached to a customized printed circuit board (Seeed Studio, Shen-
zhen, China). Electrodes were grounded through a 37-gauge wire attached to a gold-
plated pin (Mill-max, part # 1001-0-15-15-30-27-04-0), which was implanted into the
overlying cortex. Recordings were performed during once-daily sessions, 1-5 days af-
ter animals' last runway session. Electrodes were advanced 80-160 um at the end of
each session. A 15 minutes baseline was collected, after which animals were given a
single infusion of cocaine (0.750mg/kg, i.v.). The recording apparatus consisted of
a unity gain headstage (Neurosys LLC) whose output was fed to preampliers with
high-pass and low-pass lter cutos of 300 Hz and 6 kHz, respectively. Analog signals
were converted to 18-bit values at a frequency of 15.625 kHz using a PCI card (Na-
tional Instruments) controlled by customized acquisition software (Neurosys LLC).
Spikes were initially detected via thresholding to remove signals less than twofold
above background noise levels, and signals were further processed using principal
component analysis performed by NeuroSorter software. Spikes were accepted only
if they had a refractory period, determined by <0.2 % of spikes occurring within
1ms of a previous spike, as well as by the presence of a large central notch in the
auto-correlogram. Neurons that had signicant drifts in ring rates were excluded.
Drivable electrode arrays were implanted above the RMTg (AP: -7.4mm; ML: 2.1mm;
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DV: -7.4mm from dura, 10-degree angle). Placements at RMTg were veried with
FoxP1 stain.
2.3.2 Fiberphotometry
Fiber photometry was used to monitor uorescent dopamine signals using a custom
system as previously described (Cho et al., 2017; Patriarchi et al., 2018), which al-
lowed for dLight1.2 excitation and emission light to be delivered and collected via the
same implanted optical ber. Our system employed a 465 nm LED (M490F1, Thor-
labs, Inc; ltered with FF02-472/30-25, Semrock) for uorophore excitation and a 405
nm LED for isosbestic excitation (M405F1, Thorlabs Inc; ltered with FF01-400/40-
25, Semrock), which were modulated at 211 Hz and 531 Hz, respectively, controlled
by a real-time processor (RX8-2, Tucker David Technologies), and delivered to the
implanted optical ber via a 0.48 NA, 400 mm diameter mono ber optic patch cable
(Doric Lenses Inc). The emission signal from isosbestic excitation, which has previ-
ously been shown to be calcium independent for GCaMP sensors (Kim et al., 2016;
Lerner et al., 2015), was used as a reference signal to account for motion artifacts
and photo-bleaching. Emitted light was collected via the patch cable, collimated,
ltered (MF525-39, Thorlabs), and detected by a femto-Watt photoreceiver (Model
2151, Newport Co.) after passing through a focusing lens (62 561, Edmunds Op-
tics). Photoreceiver signals were demodulated into dLight1.2 and control (isosbestic)
signals, digitized (sampling rate: 382 Hz), and low-pass ltered at 25 Hz using a
second-order Butterworth lter with zero-phase distortion. A least-squares linear t
was applied for the 405 nm signal to be aligned with the 465 nm signal. Then, the
tted 405 nm signal was subtracted from 465 nm channel, and then divided by the
tted 405 nm signal to calculate DF/F values. Rats received three dierent types
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of trials that were randomly selected: reward trial, shock trial, and neutral trial. In
reward trials, a two-second auditory tone (1kHz) predicts a sucrose pellet delivery,
and reward delivery. In shock trials, a distinct auditory tone (8kHz) predicts a mild
footshock (0.7mA, lasting for 10ms). In neutral trials, a distinct auditory tone (1kHz)
was delivered with no consequences.
2.4 Histology
2.4.1 Immunostaining
Rats were transcardially perfused with saline and 10 % formalin. Brains were removed
and postxed overnight in 10 % formalin, equilibrated in 20 % sucrose, sliced into 40
µm sections in 4 or 6 series then incubated in primary antibody or mounted for Nissl
stain.
Cfos: Rats that were classied into high- and low-avoiders from their runway la-
tencies were transcardially perfused with saline and 10 oercent formalin 1h after giving
an i.p. injection of cocaine (10mg/kg), 2-5 days after their last runway latency. and
immunostained for c-Fos induced by cocaine using rabbit anti-c-Fos (1:10K, EMD
Millipore, MA, USA)in PBS with 0.25 % Triton-X and 0.05 % sodium azide. After-
ward, tissue was washed three times in PBS and incubated in biotinylated donkey
anti-rabbit secondary (1:1000 dilution, Jackson Immunoresearch, West Grove, PA)
for 30 min, followed by three 30s rinses in PBS, followed by 1 hour in avidin-biotin
complex (Vector). Tissue was then rinsed in sodium acetate buer (0.1M, pH 7.4), fol-
lowed by incubation for 5 min in 1 % diaminobenzidine (DAB). Nickel and hydrogen
peroxide (Vector) were added to reveal a blue-black reaction product.
FoxP1: Free-oating sections were immunostained for FoxP1 by overnight incu-
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bation in rabbit anti- FoxP1 (Abcam, ab16645, 1: 50,000 dilution) primary in PBS
with 0.25 % Triton-X and 0.05 % sodium azide. Afterward, tissue was washed three
times in PBS and incubated in biotinylated donkey anti-rabbit secondary (1:1000 di-
lution, Jackson Immunoresearch, West Grove, PA) for 30 min, followed by three 30s
rinses in PBS, followed by 1 hour in avidin-biotin complex (Vector). Tissue was then
rinsed in sodium acetate buer (0.1M, pH 7.4), followed by incubation for 5 min in
1 % diaminobenzidine (DAB). Nickel and hydrogen peroxide (Vector) were added to
reveal a blue-black reaction product.
GFP: Free-oating sections were immunostained for GFP by overnight incubation
in rabbit anti- GFP (1: 1000 dilution) primary in PBS with 0.25 % Triton-X and 0.05
% sodium azide. Afterward, tissue was washed three times in PBS and incubated in
biotinylated donkey anti-rabbit secondary (1:1000 dilution, Jackson Immunoresearch,
West Grove, PA) for 30 min
2.4.2 Western Blot
Western blotting was used to analyze expression levels of total GluR1 subunit (t-
GluR1) and phosphorylated GluR1 subunit at serine831 site (p-GluR1-S831), total
GluR2, and PTEN in the RMTg ,and A2A and D2 receptors in the NAshell, of
high-avoiders, low-avoiders and control. Briey, rats were sacriced 24 hours after
their last runway session and their brains were removed rapidly, and then the region
of the brain that contains the RMTg (AP,  6.8mm to  7.4mm from bregma) was
sectioned and collected the RMTg and NAC shell using a punch according to the
anatomic marks [Paxinos and Watson, 2006] and stored frozen at  80C until pro-
cessed. On the day of the experiment, tissue samples were homogenized on ice in
radio-immunoprecipitation assay buer supplemented with protease inhibitors. The
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homogenates were centrifuged at 15,000rpm for 15min at 4C, and supernatants were
collected for further analysis. For all samples, protein concentration was quantied
using a Pierce BCA Protein Assay Kit (Thermo Scientic). Samples were denatured
by boiling before being loaded (80ug) on the10 Tris-Glycine gels (Invitrogen). After
electrophoresis, the proteins were transferred to polyvinylidene uoride membranes
(Millipore, Billerica, MA, USA) and non-specic protein binding was blocked with 5
% non-fat milk for 1hat room temperature, followed by an overnight incubation at
4C with the following primary antibodies: anti-t-GluR1 (rabbit monoclonal, 1:1000;
Abcam, Cambridge, MA, USA), anti-p-GluR1-S831 (rabbit monoclonal, 1:2000; Ab-
cam), anti-pTEN, anti-A2A; anti-D2 and anti-glyceraldehyde-3-phosphate dehydro-
genase (GAPDH; mouse monoclonal, 1:1000; Santa Cruz Biotechnology, Santa Cruz,
CA, USA). The next day, the membranes were washed several times and then then in-
cubated with uorescent goat anti-rabbit or anti-mouse secondary antibodies (1:5000,
IR-dye 680 or IR-dye 800), before being imaged on an Odyssey uorescent scanner
(Li-cor Biosciences). To ensure equal loading, GAPDH expression was used as a
loading control. Separate blots were used for each protein of interest.
2.4.3 Activated RhoA Assay
RhoA activation was determined using a G-LISA (# BK124; Cytoskeleton, Denver,
CO) as previously described [Fox et al., 2018]. Briey, tissue was collected 24 hours
after the last runway session from high-avoiders, low-avoiders and control animals.
RMTg was extracted and homogenized with a Pellet Pestle (Thermo Fisher Scientic,
Waltham, MA) in lysis buer, homogenates were centrifuged, and supernatants were
snap frozen at -80C. Protein concentrations were equalized with lysis buer, and
active RhoA determined according to manufacturer's instructions.
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2.5 Statistical Analysis
All statistical analyses were completed using GraphPad Prism 7.00 and SAS v9.4.
We indicate p values <0.0001 as p < 0.0001 and provide exact p values for those
>0.0001. The level of signicance was set at p<0.05. All values were expressed as
mean ± SEM.
Since the runway latency data do not meet the assumptions of normality, the
corresponding data was log-transformed prior to hypothesis testing, which was con-
ducted based on a general linear mixed modelling (GLMM) approach. GLMMs are
especially useful for modeling longitudinal data by accounting for within-subject cor-
relation, in this case using random mouse eects. The GLMMs contained xed eects
condition, sex, trial, and a generation by trial interaction term. For analyses of la-
tency data pooled across trials 4-7, Kruskal-Wallis tests followed by a Mann-Whitney
U test for pairwise comparisons were used. analyzed by non-parametric statistical
tests. Runway data by trial was analyzed using a repeated-measures ANOVA on
rank-transformed latency data. For analyses with one variable, Kruskal-Wallis test
followed by a Mann-Whitney U test for pairwise comparisons.
Correlations were calculated according to the Spearman method. For the rest
of the behavioral data, student's t-tests and one-way ANOVA were used to assess
dierences in group means, and two-way ANOVA was used with more than one vari-
able. Main eects analyses from one-way ANOVA, two-way ANOVA or Students







Although many people experiment with drugs at some point in their lives, far fewer
develop subsequent substance use disorders. Indeed, although addictive disorders,
dened in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
(DSM5) as use disorders, are contingent on availability and use of an addictive agent,
people are dierentially vulnerable at multiple stages of the cycle of addiction, includ-
ing the initial propensity to use, transition from use to abuse, long-term addiction, and
relapse [Kwako et al., 2016]. Marked variability in addictive vulnerability has spurred
strong interest in identifying predisposing factors, risk factors and physiological pro-
cesses that underlie drug abuse and addiction [Kalivas and Volkow, 2005, Koob et al.,
2004, Olmstead, 2006, Bau et al., 2001, Belin et al., 2008, Crabbe, 2010, Stead et al.,
2006], with the goal of developing interventions to avert abuse later in life. Indeed,
during the last few decades, there has been a considerable increase in the number of
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studies assessing the neurobiological basis of individual dierences in vulnerability to
drug abuse. However, much basic research has been directed at understanding individ-
ual animals who have already progressed into addiction-like behaviors, with relatively
less study of what protective factors may help prevent acquisition or escalation of drug
use in the rst place and hence render some individuals less vulnerable to becoming
addicted. Nonetheless, a number of vulnerability factors have been examined. For
example, prior work from Huda Akil and others has shown that locomotor response
to novelty is heritable, and predictive of the rate of acquisition of drug-seeking and
that that individual dierences in response to novelty have been repeatedly linked to
drug abuse [Stead et al., 2006, Cain et al., 2005]. Moreover, impulsivity is a well-
established predictor of drug self-administration in laboratory animals and is related
to abuse vulnerability in humans [Perry and Carroll, 2008]. Others have shown people
who score higher on the Zuckerman sensation-seeking questionnaire or the Cloninger
novelty-seeking questionnaire also report more frequent drug use [Zuckerman et al.,
1993] and are more sensitive to the subjective and reinforcing eects of drugs. How-
ever, considerable unexplained variance remains, suggesting that these phenotypes
are just some of many possible protective elements against/predictors of addiction
vulnerability. We hypothesize that drug-induced aversion also plays major roles in
drug-resistance.
Since the rst experimental demonstration that a drug of abuse supports instru-
mental behavior, drugs have been discussed in the context of their rewarding eects,
which are assumed to drive and maintain drug-taking behavior. Indeed, drug reward
has been fundamental in the formulation of most models of drug use, abuse, and
addiction. Over the last several decades, however, drugs of abuse have been increas-
ingly recognized as complex pharmacological compounds producing multiple stimulus
eects, not all of which are rewarding [Wise et al., 1976, Stolerman, 1992, Koob and
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Le Moal, 1997, Verendeev and Riley, 2012]. The aversive eects of such drugs, for
example, have been described by a number of researchers working in the eld, al-
though few attempts have been made to investigate the role of these aversive eects
in drug taking. Recently, the aversive eects of drugs of abuse, that have been well
described for all major classes of drugs of abuse [Verendeev and Riley, 2012] and have
been found to occur independent of the drugs' rewarding eects [Verendeev and Ri-
ley, 2012], have also been increasingly recognized [Verendeev and Riley, 2012, Goudie,
1979, Gaiardi et al., 1991a, Riley, 2011]. In particular, cocaine's aversive eects are
experimentally robust, having been studied for decades by several groups [Geist and
Ettenberg, 1997b, Ettenberg et al., 1999, Ettenberg et al., 2015, Jhou et al., 2013].
Particularly elegant experiments by Ettenberg's group have shown that single doses
of cocaine produce an initial rewarding phase followed by an aversive crash about 15
minutes later [Ettenberg et al., 1999] that is sucient to condition a net aversion to
cocaine, that in most (but not all) animals, is strong enough to overcome cocaine's
rewarding eects [Ettenberg, 2004, Jhou et al., 2013]. In this study, we further found
that the aversive eects of cocaine were more individually variable, and much better
predictors of individual dierences in cocaine-seeking, than the rewarding eects, and
that the resulting avoidance response was not unique to the eects of the drug and
not inuenced by confounding phenotypes.
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3.2 Results
3.2.1 Individual Sprague-Dawley rats show large variation in
cocaine-avoidance
Prior studies noted that individual cocaine doses produce immediate rewarding ef-
fects followed a few minutes later by a delayed aversive crash, producing avoidance
responses on a runway operant cocaine-seeking task [Ettenberg et al., 1999, Geist
and Ettenberg, 1997b, Ettenberg, 2004]. To examine more precisely the distribution
of this variation, we tested 105 rats on the runway task, and found, as expected, a
gradual increase in latencies over the 7 trials, with average latencies over the last 4 ses-
sions varying considerably between individual rats (Fig. 3.1A). Interestingly, latency
distributions could be tted to a bimodal distribution (Fig. 3.1B) separated by a
median of 256 seconds that also corresponds to the notch between the bimodal peaks.
Hence, we subsequently grouped animals into high- or low-avoiders using this thresh-
old. Consistent with prior reports, the average run latencies were low for trials 1-2 and
signicantly higher for trials 4-7, reecting the development of conditioned avoidance
(Wilcoxon test; low avoiders: W=132, n=20, p=0.012; high-avoiders: W=496, n=31,
p<0.0001) (Fig. 3.2A). Notably, run latencies remained low in control animals run-
ning to receive saline (two-way ANOVA, Bonferroni test, n=6-26 per group, p<0.01)
(Fig. 3.2B), indicating that increased latencies were due to cocaine exposure, rather
than habituation to the apparatus or other non-specic reductions in exploratory ac-
tivity. Latencies to obtain cocaine did not dier between males and females (Mann
Whitney, n=22-26 per group, U=224.0, p=0.21) (Fig. 3.2D). In rats running for
cocaine, increased latencies to obtain cocaine were also accompanied by increasing
number of run direction reversals, reecting alternating approach and retreat behav-
55
iors posited to be due to cocaine's dual rewarding and aversive eects [Ettenberg
et al., 1999], which correlated with run latencies (n=48; r2=0.2879; p=0.0001) (Fig.
3.2C).
In all the above tests, the runway apparatus was initially novel to the animal,
potentially confounding the current results because novelty-induced locomotion has
also been shown to correlate with cocaine seeking [Stead et al., 2006]. Hence, we
had attempted to minimize novelty-related eects by habituating all animals to the
runway apparatus prior to cocaine trials for up to 3 trials. To further control for this
possible confound, we then explicitly measured locomotor activity in a novel oper-
ant chamber distinct from the runway apparatus and found no correlation between
locomotor activity and run latencies (males: n=25, r2=0.06, p=0.25, females: n=18,
r2=0.09, p=0.23) (Fig. 3.2E).
Prior studies had shown that high doses of cocaine can be toxic, presumably
contributing to aversive eects, but our dose (0.75mg/kg, or about 0.25mg per rat)
is well below such levels [Smith et al., 1991], and is similar to hundreds of other self-
administration studies. Furthermore, a cohort of animals tested on a half-size dose
(0.375mg/kg, or about 0.125mg per rat) showed a similar distribution of latencies
to obtain cocaine. In particular, neither the means nor standard deviations diered
between the two doses (298 ± 94 seconds vs 344 ± 103 seconds avg ± SEM for full
and half size doses, n=16-25 per group, mean: Mann Whitney, U=197.0, p=0.94;
standard deviation: p=0.44) (Fig. 3.2F).
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3.2.2 Cocaine-avoidance on the runway is specic to the ef-
fects of cocaine and is independent of control behaviors
To assess if the dierences in runway latencies between high- and low-avoiders are
driven specically by the properties of cocaine, we controlled for several potentially
confounding phenotypes by testing the animals on a battery of behaviors. First,to
rule out the inuence of exploratory activity on run latencies, we tested the ani-
mals on a locomotor task in a novel chamber and found no dierence in novelty-
induced locomotion between high- and low-avoiders (Fig. 3.3B) (n=8-9 per group,
t(15)=0.3191, p=0.750). To further explore the possibility that dierences in runway
behavior might be due to dierences in generalized motivation to seek rewards, we
tested these high- and low-avoider rats in a progressive ratio food-seeking task (PR).
In this task, animals leverpress for food pellets, with the required number of presses
per pellet increasing progressively throughout the task; high- and low-avoiders had
similar breakpoints (Fig. 3.3C) (n=6 per group, t(10)=0.4404, p=0.67).
We next examined whether dierences in runway latency (which presumably re-
ect dierences in the relative rewarding versus aversive qualities of cocaine) gener-
alize to other tasks in which an operant action produces both rewarding and aversive
outcomes. We used a progressive punishment task (PP) in which rats pressing for
food pellets also receive concurrent footshocks whose intensity progressively increases
throughout the task. A shock breakpoint is reached when leverpressing is largely
inhibited, indicating the amount of shock an animal will endure for a given reward,
and this breakpoint was not dierent between the two ospring groups (Fig. 3.3D)
(n=6 per group, t(10)=0.4404, p=0.67). In addition to that, testing on the elevated
plus maze showed that high- and low-avoiders had no dierences in anxiety levels, as
measured by time spent in the open arms of the maze (n=7 per group, t(12)=0.2031,
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p=0.84) (Fig. 3.3E).
Finally, we wanted to assess if high-avoiders' aversive response to cocaine is not
specic to the drug and generalizes to other aversive stimuli. We therefore tested
both groups on a lithium chloride CPA test as well as on a their rate of escape from
an acute shock in a two-way shuttlebox. We found no signicant dierence in the
CPA score (Fig. 3.3F) nor in escape latencies at dierent shock intensities between
high- and low-avoiders, indicating that high-avoiders are not simply hypersensitive
to all aversive stimuli (Fig. 3.3G). Altogether, these ndings demonstrate that the
dierences observed in run latencies between the two groups were not likely due to
general dierences in exploration, motivation, learning capacity or anxiety.
3.2.3 Cocaine has dual rewarding and aversive eects, with
the aversive component driving individual variation in
drug-seeking behavior
Although we had hypothesized that high-avoider rats exhibit stronger aversive eects
of cocaine, their long latencies to reach the goal compartment would also be con-
sistent with them experiencing lower rewarding eects of the drug. To address this
issue, we tested high- and low-avoiders in a CPP/CPA task in which rats were either
placed into conditioning chambers immediately after receiving an infusion of i.v. co-
caine (0.75 mg/kg), or 15 minutes afterwards. We found that rats with high (> 256
s) or low (<256 s) run latencies both showed robust cocaine CPP when placed into
chambers immediately after cocaine infusions. However, high-latency rats showed
dramatically higher CPA than the low-latency rats (one-way ANOVA, Bonferroni
test, n=7-8 per group, p>0.9999 and, p=0.04, respectively) (Fig. 3.4A). Correla-
tional analysis of individual animals showed similar results, in which run latencies
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correlated with CPA but not CPP scores (n=15, r2=0.48, p=0.004, r2=0.028, p =0.5
respectively) (Fig. 3.4B). These results are consistent with prior reports [Ettenberg,
2004] and suggest that individual variation in cocaine-seeking likely depends more on
variation in cocaine's aversive eects, rather than its rewarding eects, which were
relatively constant across animals.
Because cocaine's crash has long been known to be characterized by dysphoria,
irritability, anxiety, and cravings [Gawin, 1991, Resnick et al., 1977b, Williamson
et al., 1996b], we compared high and low avoider animals on the elevated plus maze
(EPM) 15 minutes after i.v. cocaine infusions. When tested on the EPM after
saline infusions, high and low-avoider animals did not dier signicantly in time spent
exploring the open arms of the EPM. However, relative to saline, cocaine infusions
induced a signicant decreases in open arm time in the high-avoiders but not low-
avoiders (paired t-test: low-avoiders: n=8, t(7)=0.596, p=0.57; high-avoiders n=8,
t(9)=3.736, p=0.0047) (Fig. 3.5A), suggesting enhanced anxiety during this period
in highavoiders only. Analysis of individual animals within groups further showed
that open arm time correlated with run latencies 15 minutes after cocaine (n=18,
r2=0.32, p=0.015) but not saline injections (n=18, r2=0.028, p=0.5) (Fig. 3.5B).
The decrease in open arm time in high avoiders was not explained by a decrease in
locomotor activity, since high- and low-avoiders did not dier in their total arm entries
on the EPM either with or without cocaine infusion (paired t-test: Low-avoiders: n=6,
t(5)=0.515, p=0.63; high-avoiders n=6, t(5)=1.346, p=0.24) (Fig. 3.5C).
3.3 Discussion
The complexity of the addictive phenotype poses several challenges in identifying
specic areas of vulnerabilities, as addiction likely results from a conuence of multi-
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ple independent vulnerabilities, that also interact with environmental factors, drug-
induced neurobiological changes, and comorbidity with other neuropsychiatric dis-
orders and personality traits [Stone et al., 2012, Wong and Schumann, 2008, Belin
et al., 2016, Gottesman and Gould, 2003]. We posit that the current results suggest
that the challenges posed by the complexity of human behavior could be addressed by
studying animal models in which intermediate endophenotypes of specic behavioral
elements can be more readily isolated and discerned. Hence, we sought strategies to
examine such endophenotypes in an animal model using tasks that deconstruct the
cost-benet decision processes into its building block and allow us to subdivide the
complexity of the addictive phenotype into smaller constituents that could then be
investigated independently. Indeed, it is worth noting that the control tasks exam-
ined could identify phenotypes that are important components of addiction in their
own right and could inuence dierent stages of addiction, despite our focus being on
individual dierences in cocaine avoidance.
To study cocaine-avoidance, we require a model that is sensitive to both positive
and negative eects of drug-seeking, akin to the human experience. A substantial
body of literature from the lab of Aaron Ettenberg has used the runway operant
for this purpose [Ettenberg, 2004]. Although the runway task is not as widely used
as lever-pressing for cocaine self-administration, we have chosen it in this study for
several reasons. First, the single-trial nature of the runway task greatly helps to
isolate the aversive eects of cocaine, since the aversive responses are not masked
by subsequent doses. Another advantage of the runway task is that the limited
availability of cocaine more closely resembles early drug use in humans, where users
more commonly start with individual trial doses rather than the more unbounded
amounts available in conventional self-administration paradigms at close to zero cost.
Using this task, we found that, even though drug addiction is commonly viewed as
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a disorder of reward learning, it was variations in avoidance learning that explained
more of the variability in drug-seeking, where avoidance responses to cocaine slowed
the initial acquisition of drug-seeking.
In summary, the current study identied an important behavior, cocaine avoid-
ance, that could inuence addiction propensity. However, it remains unknown what
anatomical substrates and molecular targets reside within these circuits, and why
they behave so dierently in dierent individuals. Discovering previously unknown
molecular correlates of addiction-propensity would improve our understanding, pre-
diction, and treatment, of addiction. Such a nding, if applicable to humans, would
have complex but important implications for our theoretical understanding of how
individual dierences contribute to drug abuse liability.
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Figure 3.1: Two populations of rats observed on the runway task. (A) Rats showed
on average a gradual increase in latencies over 7 trials, but with average latencies
varying considerably between individuals over the last 4 sessions . (B) Latencies were
bimodally distributed with two roughly equal size peaks separated by a median of
256 seconds residing in the valley between peaks. We subsequently grouped animals
into high- or low-avoiders using this threshold.
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Figure 3.2: Individual Sprague-Dawley rats show large variation in cocaine-avoidance
(A) Individual outbred Sprague-Dawley (SD) rats showed large variation in their
increase in run latencies after 4-7 conditioning trials. (B) On average, latencies to
obtain cocaine increased progressively with the number of trials in both males and
females, compared to animals receiving saline, which showed consistently short la-
tencies across all trials. (C) Average run latencies were not signicantly dierent
between males and females (D) Latency to obtain cocaine did not correlate with
novelty-induced locomotion, for either male or female rats. (E) Animals tested on
a half-size dose (0.375mg/kg, or about 0.125mg per rat) showed similar latencies to
obtain cocaine (298± 94 seconds vs 344± 103 seconds avg ± SEM for full and half
size doses).
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Figure 3.3: High- and low-avoiders do not dier in control tasks (A) Low- and high-
avoiders do not dier in (B) novelty-induced locomotion, (C) punishment resistance,
(D) food-seeking, (E) elevated plus maze, (F) lithium chloride CPA or (G) escape
latency from shock. *** p<0.001.
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Figure 3.4: Cocaine has dual rewarding and aversive eects, with the aversive com-
ponent driving individual variation in drug-seeking behavior (A) Cocaine produces
strong CPP (grey bars) for both high- and low-avoiders if rats are placed into con-
ditioning chambers 0-15 minutes after iv cocaine infusions. However, high-avoiders
(but not low-avoiders) showed a CPA (red bars) when rats were placed into chambers
15-30 minutes post-infusion. (B) Runway latencies did not correlate with CPP scores
on the 0-15 minute condition, but strongly correlated with CPA scores in the 15-30
minute conditions. * p<0.05, **** p<0.0001.
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Figure 3.5: High cocaine-avoiders have enhanced anxiety during the aversive phase
of the drug (A) Relative to saline, cocaine infusions induced a signicant decreases in
open arm time in the high-avoiders but not low-avoiders. (B) Analysis of individual
animals within groups further showed that open arm time correlated with run latencies
15 minutes after but not saline injections. (C) high- and low-avoiders did not dier




Adaptations in RMTg Underlie
Individual Dierences in Cocaine
Avoidance
4.1 Introduction
We have already found that cocaine's aversive eects vary greatly between individual
animals, with high cocaine-avoider and low cocaine-avoider animals exhibiting strong
or weak aversive responses to cocaine, respectively, and that cocaine avoidance is
powerfully protective against drug-seeking in those high-avoiders. Because naturally
occurring high-avoider rats did not exhibit locomotor impairments, resistance to pun-
ishment, lack of reward motivation or heightened anxiety, we thus sought to identify
what mechanisms drive the normal variations between high- and low-avoiders in re-
sponse to cocaine, in order to determine whether these mechanisms might drive more
selective modulation of drug-seeking. The reasons for these variations are not yet
understood, but we previously reported that RMTg lesions markedly reduce run-
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way latencies to obtain cocaine [Jhou et al., 2013], with this eect being replicated by
temporally restricted optogenetic inhibition of the RMTg during a time window 15-30
minutes after cocaine infusions [Jhou et al., 2013]. Hence, RMTg activity during this
time window critically drives cocaine avoidance, prompting us to examine whether
cocaine might activate the RMTg dierently during this window in some rats but not
others.
To address these questions, and in collaboration with a slice electrophysiologist
in the lab (Dr. Jerey Parrilla-Carrero), we generated data indicating that RMTg
activation by cocaine depends on glutamatergic changes at the RMTg involving cal-
cium permeable AMPA receptors (CP-AMPARs) residing on VTA-projecting RMTg
neurons. Specically, we found increases in glutamate release in high-avoider and
a post-synaptic depontentiation characterized by a decrease in CP-AMPAR in low-
avoiders. To further characterize the sources of this dierence at the cellular level,
we manipulated upstream cellular eector that may regulate glutamate transmis-
sion. We focused on Ras homolog family member A (RhoA), Rho-associated pro-
tein kinase (ROCK) and phosphatase and tensin homolog deleted on chromosome 10
(PTEN) (RhoA/ROCKs/PTEN) cellular pathway, as it has been previously shown to
be involved in glutamate transmission and plasticity [Du et al., 2013, Jurado et al.,
2010], and all the molecules involved in this pathway are highly expressed in the
RMTg. Hence, we tested the hypothesis that dierence in RhoA/ROCKs/PTEN
activity modulate glutamate transmission to promote/prevent heterogeneity in co-
caine avoidance behavior. As expected, we found that pharmacological manipulation
of RhoA/ROCKs/PTEN pathway activity, in fact was involved on individual behav-
ioral dierences in cocaine seeking, suggesting that manipulation of this cellular signal
may be use in the future for therapeutic benet.
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4.2 Results
4.2.1 High cocaine avoiders show greater neuronal activation
in the RMTg
Having established that cocaine avoidance diers greatly between animals, we next
sought to identify the neural substrates of these individual dierences. Previous
work has implicated activation of the serially connected EPN, LHb and RMTg brain
regions as key drivers of aversive reactions to cocaine [Jhou et al., 2013, Meye et al.,
2015, Meye et al., 2016]. However, it is not known whether individual dierences in
behavior are due to variations in one or more of these regions. Hence, in a subset of
rats screened for cocaine avoidance, we examined cocaine-induced expression of the
immediate early gene cFos in the EPN, LHb, and RMTg (Fig. 4.1A). After a single
infusion of cocaine given 1 hour before sacrice, cFos counts in the RMTg, EPN,
and LHb, were all higher than in rats receiving saline (one-way ANOVA, Tukey's
test: n=5-7 per group, RMTg: F=86.88, p<0.0001, LHb: F=12.53, p=0.0013 (low-
avoiders vs saline) and p=0.0009 (high-avoiders vs saline), EPN:F=19.5, p<0.0001)
(Fig. 4.1B). Furthermore, cocaine-induced cFos in the RMTg was much higher in
high- than low-avoider rats (Fig. 4.1B; one-way ANOVA, Tukey's test, n=7 per group,
F=86.88, p=0.0004). However, cFos counts unexpectedly did not dier between high-
and low-avoider rats in the EPN and LHb (one-way ANOVA, Tukey's test, n=7
per group, LHb: F=12.53, p=0.9758, EPN: F=19.5, p=0.9789). Further analysis
of individual rats revealed that the number of cFos cells in the RMTg positively
correlated with the mean latency of the last 4 sessions in high avoiders but not low
avoiders (r2=0.7455, p=0.0123; r2 = 0.0915, p = 0.51, respectively (Fig. 4.1C). These
results suggest that although the EPN and LHb are equally activated by cocaine in
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high- and low-avoiders, the RMTg itself is activated more strongly in high-avoiders
than in low-avoiders.
Because cFos is an indirect measure of neuronal ring with poor temporal resolu-
tion, we further evaluated RMTg responses to cocaine using in vivo electrophysiology
in the RMTg of both high- and low-avoiders (Fig. 4.1D). We recorded 71 RMTg
neurons, with 35 neurons from 11 high-avoider rats and 36 from 13 low-avoider
rats. RMTg neurons showed decreased ring during the rst 15 minutes after co-
caine infusion (when cocaine is rewarding), that did not dier between high and low
avoiders (unpaired t test, n=26-33 per group, t(57)=0.09653, p=0.9234). However,
high avoiders showed signicantly higher ring relative to low avoiders 15-45 minutes
after cocaine infusion, overlapping the period when cocaine is aversive (unpaired t
test, n=26-32 per group, t(56)=3.962, p=0.0034) (Fig. 4.1D). Furthermore, as with
cFos measures, correlation analysis in individual rats revealed that RMTg neuron re-
sponses 15-45 minutes but not 0-15 minutes post cocaine infusion positively correlated
with individual's runway latency (Fig. 4.1E, r2=0.5661, p=0.015 and r2=0.0236,
p=0.6927). These results further corroborate that, although the EPN, LHb, and
RMTg are serially connected structures that all mediate the aversive properties of
cocaine, only the RMTg exhibited individual dierences in responses to cocaine that
correlated with individual dierences in behavioral avoidance.
4.2.2 Cocaine-avoiding rats exhibit enhanced excitability of
VTA-projecting RMTg neurons.
Although a majority (55 %) of RMTg neurons project to the VTA, some do not, and
these in vivo recordings do not indicate the target of the cocaine-activated neurons.
Hence, we further examine possible cellular changes underlying these dierences in
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RMTg activity, Jerey patch clamped VTA-projecting RMTg neurons labeled by in-
jections into the VTA of the retrograde tracer CTb conjugated to the uorescent
molecule AlexaFluor555 (CTB-555) (Fig. 4.2A). We rst characterized excitatory
synaptic transmission in high- and low- cocaine avoider rats and found that high-
avoider rats had a higher sEPSC frequency compared to both saline controls and
low-avoiders, consistent with presynaptic alterations. To further assess presynaptic
dierences, we used the paired-pulse ratio (PPR), and found a signicantly decreased
PPR (Fig. 4.2C; One-way ANOVA F(2,46) = 7.631, P = 0.0014), in the high-avoiders
in compared to both low-avoiders (Tukey's test: t(46)=5.209, p= 0.00172) and saline
controls (t(46)=3.92, p= 0.021), consistent with increased glutamate release probabil-
ity. In addition to these presynaptic eects, analysis of sEPSC decay times revealed
faster decay times in low-avoider rats compared to saline and high-avoider rats, con-
sistent with the possibility of altered postsynaptic function.
Our observation of slower sEPSC decay times in high-avoider rats suggest the
strong possibility of there being post-synaptic dierences between phenotypes in the
RMTg, in addition to the pre-synaptic dierences noted. To that end, we calculated
the rectication index from IV curves constructed from pharmacologically isolated
AMPAR-mediated eEPSCs in VTA-projecting RMTg neurons (Fig. 4.2A). Surpris-
ingly, we detected a strong voltage-dependent blockade of AMPAR-eEPSCs in VTA-
projecting RMTg neurons of the saline control and high-avoider rats (rectication
index: saline control = 0.4513 +/- 0.0468, n = 8 cells/4 rats; high-avoiders = 0.4164
+/- 0.04615, n = 12 cells/ 5 rats; Fig. 4.2A- inset), supporting the presence of synap-
tic CP-AMPARs in these groups. In contrast, low-avoiders displayed more linear
IV relationships in the AMPAR-eEPSC (rectication index: 0.8094 +/- 0.1242, n
= 6 cells/3 rats; Fig. 4.2D-inset; One-way ANOVA, F(2,23) = 6.054, p= 0.0077),
low-avoider rats compared to saline (Tukey posttest: t(23)=3.906, p=0.0287), and
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high-avoider rats (Tukey posttest: t(23)=4.766, p=0.0071), consistent with lower
proportions of CP-AMPARs (Isaac et al., 2007; Clem and Huganir, 2010) at these
synapses. We further examined AMPAR subunit composition in VTA-projecting
RMTg neurons using a selective pharmacological blocker of AMPAR-mediated EP-
SCs, NASPM 100uM (Fig. 4.2E). We found a signicant NASPM-induced reduc-
tion of the amplitude of AMPA-EPSC in saline control and high-avoider, but not
low avoider rats (two-way ANOVA: phenotypes, F(2, 22)= 4.054, p=0.0317; time,
F(15, 330) = 7.089, p = 0.0001.; interaction, F(30,330)= 3.054, p=0.0001, Bonferroni
posttest: min 14 t(352)= 5.278, p=0.000647, min 15 t(352)= 5.661, p=0.000225, min
16 t(352)= 5.011, p=0.0013 for saline vs low-avoiders, and min 14 t(352)= 5.291,
p=0.00062., min 15 t(352)= 5.856, p= 0.000128, min 16 t(352)= 5.904, p=0.000111,
low-avoiders vs high-avoiders respectively).
Finally, compared with the saline-control and high-avoiders the AMPA/NMDA
ratio was signicantly lower in VTA-projecting RMTg neurons from low-avoider rats
(Fig. 4.2B)(One-way ANOVA: F (2,45) = 5.71, p = 0.0061; Bonferroni post-test,
saline-control vs low-avoiders t = 3.029; p = 0.0121; Low-avoiders vs high-avoiders
t = 2.665; p = 0.031, saline-control vs high-avoiders t = 0.3942; p = 0.999). This
decreased CP-AMPAR mediated transmission could increase the threshold for acti-
vation of these neurons and consequently reduce conditioned avoidance to cocaine.
In support of this hypothesis, rats that received intra-RMTg infusion of either 2-
pyrrolidinone or NASPM displayed a slower or faster latency to reach the goal box
than rats that received intra-RMTg infusion of saline, respectively (Fig. 4.3B), al-
though only signicant for NASPM (one-way ANOVA, n=6-11 per group, F=9.012,
p=0.0021; Tukey's test; 2-pyrrolidinone vs control: p=0.1130; NASPM vs control:
n=6-11 per group, , p=0.043) (Fig. 4.3C), further suggesting that CP-AMPA recep-
tor signaling in the RMTg is key for development of this behavior. Together, these
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data suggest that CP-AMPARs in the RMTg inuence constitute a neural substrate
driving variability in cocaine aversion and in turn the motivation to seek cocaine.
4.2.3 RhoA/Rock downregulates glutamatergic signaling, and
bidirectionally modulates cocaine-seeking via PTEN
Taken together, the above results show that conditioned cocaine avoi- dance requires
activation of CP-AMPAR in RMTg, and that cocaine-induced reduction in the trans-
mission of this receptor on VTA-projecting RMTg neurons may be a source that
confers variability in this eect of cocaine. Although many mechanisms haves been
posited to down-regulate CP-AMPAR from the synapse, the RhoA/ROCKs/PTEN
pathway has been recently showed to be a key player in this regulation. For exam-
ple PTEN's lipid phosphatase activity is able to drive depression of AMPA receptor-
mediated synaptic responses [Jurado et al., 2010], and RhoA is upregulated in stressed
mice and contributes to the loss of dendritic arbor [Fox et al., 2018]. Moreover, our
data With RNA sequencing showed that these proteins are highly expressed in the
RMTg; out of several PTEN activators, ROCK was the most highly expressed (
one-way ANOVA; n= 4 per group, F=68.27; p<0.0001; Tukey's test: ROCK vs oth-
ers: p<0.0001)(Fig. 4.5B), and out of several ROCK activators, RhoA also had the
highest expression (one-way ANOVA; n= 4 per group, F=125.4; p<0.0001; Tukey's
test: RhoA vs others: p<0.0001) (Fig. 4.5A). Therefore, due to the role of these
molecules on glutamate plasticity and their expression at the RMTg, we rationalized
that the activity of any of them may inuence glutamate transmission to alter co-
caine avoidance behavior. To investigate the role of PTEN in avoidance behavior,
we microinfused VO-OHpic trihydrate (VO-OHpic) (2.5pmol in 0.5µL), a highly se-
lective PTEN inhibitor [Mak et al., 2010, Mak and Woscholski, 2015] in the RMTg,
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and found that run latencies were signicantly increased compared to saline-infused
rats (one-way ANOVA: n=5-9 per group, F=4.504, p=0.04; Tukey's test; control
vs VO-OHpic: p=0.037). As a next step, we showed that bilateral microinfusions
of a RhoA inhibitor Rhosin (30 umol/L, 0.5 uL infusion on each side) or ROCK
activator (narciclasine) (2.5pmol in 0.5µL) into RMTg produced large increases or
reductions in run way latency, respectively, although not reaching signicance com-
pared to the control group (Fig. 4.4A-C). Specically, narciclasine was given to a
group of high-avoiders (from their average run latencies of trials 4-7) 30 minutes be-
fore their 8th trial; narciclasine dramatically reduced latencies for that trial and the
next one (9th trial, saline microinfused), but the animals recovered on the 10th trial
(saline microinfused), suggesting that we did not inadvertently mechanically damage
the RMTg (Repeated-measure one-way ANOVA, n=4-7 per group, F=5.71, p =0.006;
Tukey's test; average run latencies vs narciclasine: p=0.0043; average run latencies vs
1st saline: p=0.002; average run latencies vs 2nd saline: p=0.61) (Fig. 4.4B). To cor-
roborate those ndings with slice electrophysiology, we found that bath application
of narciclasine, which indirectly activates PTEN via ROCK [Fürst, 2016], reduced
amplitudes of evoked EPSCs in RMTg (Fig. 4.4E) and also reduced inward rectica-
tion (i.e. increased ratio of currents at +40/-70mV) (Fig. 4.4D), both consistent with
reductions in glutamatergic signaling through CP-AMPARs and in agreement with
our in vivo ndings. Finally, to prove that modulating Rho/ROCK in our paradigm
ultimately modulates avoidance response through PTEN, and not other downstream
targets, we microinfused a cocktail of narciclasine + VO-OHpic and found that run
latencies were signicantly increased (one-way ANOVA: n=5-9 per group, F=4.504,
p=0.04; Tukey's test; Narciclasine vs VO-OHpic + narciclasine: p=0.02) (Fig. 4.4A).
Hence, PTEN activation appears to reduce cocaine's aversive eects via reduction of
glutamate signaling in the RMTg.
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4.2.4 Protein quantication
Even though manipulating the pathway of interest provides insight into what might
be dierent between high- and low-avoiders after exposure to cocaine in the runway, it
does not necessarily mean that this pathway reects the biological dierences between
these two groups. We therefore quantied some proteins of interest along this pathway
using western blot or ELISA. Total Glutamate Receptor Ionotropic, AMPA 1 (GluR1)
subunit (t-GluR1) and phosphorylated GluR1 subunit at serine831 site (p-GluR1-
S831), total Glutamate Receptor Ionotropic, AMPA 2 (GluR2), and PTEN receptor
subunit protein levels were examined by western blot analysis in whole homogenate
prepared from RMTg extracted from the brains of high- vs low-avoiders 24 hours after
their last runway session. High-avoiders and low-avoiders had similar expression of t-
GluR1 and GluR2 relative to control animals. However, relative to control rats, only
low-avoiders had reduced expression of p-GluR1-S831, consistent with our previous
ndings (Fig. 4.5C). Interestingly, we found that PTEN was not dierent between
the two groups of animals, but its upstream activator RhoA was; we quantied the
amount of active RhoA using a modied ELISA protocol [Fox et al., 2018] in those 3
groups of animals and found that low-avoiders had increased active RhoA after runway
compared to low-avoiders and control (n=4-5 per group, one-way ANOVA, F=6.081;
p=0.0166; Tukey's test: high-avoiders vs low-avoiders p=0.0183) (Fig. 4.5D). The
protein quantication with western blot was done with only one sample per animal
group, which makes the data very preliminary and its interpretation very limited.
4.3 Discussion
In this study, we have elucidated novel molecular mechanisms driving aversive con-
ditioning to cocaine and their individual dierences, that ll major gaps in our un-
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derstanding of drug-seeking, and that someday could be exploited for therapeutic
benet. Indeed, aversive eects of drugs have already been used as therapeutics, as
in the case of disulram (Antabuse) which inhibits ADLH2, thereby reducing alcohol
intake by greatly potentiating its aversive eects. Following the same principle, we
have attempted to understand the molecular basis of cocaine aversion in an attempt
to indentify tharapeutic targets. We have shown that cocaine's aversive eects vary
greatly between individual animals and that these variabilities were mediated by cor-
responding dierences in RMTg cellular responses to glutamate. We found that VTA-
projecting RMTg neurons were more excitable in high-avoiders, and showed LTD in
low-avoiders, and that this GluR1 downregulation was driven by dierential activity
of PTEN, previously implicated in synaptic plasticity [Jurado et al., 2010]. Recently,
a role for RhoA and its eector kinase ROCK in positive regulation of PTEN activity
has been reported [Li et al., 2005]. Indeed, ROCK can increase the phosphorylation
and activity of PTEN, through an unknown mechanism but most likely involving a
physical interaction with PTEN [Li et al., 2005, Meili et al., 2005]. Although the
upstream signals that control this pathway RhoA/ROCK/PTEN remain unknown,
we have demonstrated that this pathway is upregulated in low-avoider animals. How-
ever, egarding the use of current PTEN inhibitor in this research, some aspects should
be taken into consideration to endorse the assumption that the observed experimen-
tal eects of the compounds are, in fact, due to PTEN inhibition. These include,
among others, dose-response analysis using more than one inhibitory compound; the
analysis of GluR1 content as an indirect readout of PTEN inhibition; the compara-
tive analysis of both PTEN-positive and PTEN-negative cells; and the comparative
analysis of GluR1 with PTEN-knockdown, if feasible. Building on this data, we thus
seek to further characterize these cellular mechanisms of cocaine avoidance, their dif-
ferential regulation between individuals, and the possibility of modulating them for
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therapeutic benet.
Even our current ndings, albeit still at the beginning of the work, can already
be exploited for potential therapy. Indeed the PTEN inhibitor VO-OHpic had only
minimal eect on RMTg membrane current when delivered alone (unpublished obser-
vations), suggesting it could potentiate cocaine aversion with relatively fewer eects
in cocaine's absence. This type of allosteric modulator, which regulates responses
to ligand without activating the receptor on its own have garnered increasing at-
tention in drug-discovery due to their potentially greater functional selectivity than
traditional agonists and antagonists [Anastasio et al., 2013, Nussinov and Tsai, 2013].
Moreover, in addition to its roles in cocaine avoidance, the RMTg plays broad roles
in aversive learning, anxiety and punishment [Vento et al., 2017], potentially compro-
mising attempts to modulate these pathways therapeutically. Interestingly, because
high-avoider rats did not exhibit locomotor impairments or heightened anxiety, we
posited that the biological mechanisms underlying high- versus low-avoider pheno-
types involving PTEN can apparently modulate drug-seeking without aecting other
non-drug behaviors, thereby constituting a more ideal mechanism to target for ther-
apeutic intervention.
However, despite PTEN being an intriguing therapeutic target, more eorts are
required to dene relevant indications for a reduction of PTEN's functional dose.
Indeed, PTEN's risky prole as a tumor suppressor has to be considered. While
recent studies suggest a possible therapeutic window for PTEN dose reduction without
triggering tumorigenesis, dysfunctional outcomes of PTEN deletion in the past have
raised questions over its therapeutic suitability [Gutilla et al., 2016, Liu et al., 2010,
Pun et al., 2012, Williams et al., 2015] and global manipulation of the PIP3 pathway,
particularly targeting a tumor suppressor such as PTEN, is unlikely to be considered
for therapeutic intervention in humans. To address this issue, important eorts have
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already been made to develop specic and biologically active small molecule PTEN
inhibitors, and to validate them as suitable experimental and clinical tools. This
has provided compounds targeting PTEN that are widely used in research, as well
as the proof-of-concept that PTEN pharmacological inhibition could be benecial
for human welfare in specic diseases or conditions. Moreover, chemical tools are
required that allow selective modulation of the various PTEN functions, and there
are already groups that have already developed some of those biologically active
peptides. As a treatment for Alzheimer's disease for example, one group developed
a cell-permeable peptide that competes intracellular PTEN-PDZ interactions and
targeted PDZ-dependent interactions of PTEN (preserving its catalytic activity) to
disengage the cascade of events triggered by Abeta, therefore preventing synaptic and
cognitive dysfunction. Interestingly, and relevant to this study, they found that PTEN
was engaged by Abeta in a manner that resembles synaptically induced LTD, and
that the peptide rescued synaptic function and mouse cognitive decits, in parallel
with protecting from Abeta-induced NMDAR-dependent long term depression and
synaptic toxicity events, a phenomenon which was dependent on PTEN recruitment
to synaptic spines through PTEN-PDZ interactions [Knafo et al., 2016]. But again,
PTEN specicity of these molecules is intrinsically limited due to the ubiquity of PDZ
motifs and recognition elements [Liu et al., 2010].
Alternatively, antagonists derived from PTEN interaction partners have been re-
ported such as 3L4F, a truncated peptide from an intracellular loop of the 5-HT2C
receptor (5-HT2CR), which was found to prevent PTEN-5-HT2CR complex forma-
tion and to decrease PTEN-mediated dephosphorylation both in vitro and in vivo.
The ability to selectively target this proteinprotein interaction for a receptor that
is found predominately in the brain [Anastasio et al., 2013] also suggests that resul-
tant therapeutic compounds will have very limited side-eect proles. Such allosteric
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modulation of 5-HT2CR signaling presents a new therapeutic approach in psychi-
atric disorders in which disrupted 5-HT2CR signaling is implicated. Getting a better
understanding of PTEN's structure and how it interacts with GluR1 to cause its
internalization gives hope toward potential targeted drug development.
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Figure 4.1: High cocaine avoiders show greater neuronal activation in the RMTg.
(A) 24hours after being tested on the runway, animals were split into high- and low-
avoiders to examine dierences cocaine-induced expression of the immediate early
gene cFos in the EPN, LHb, and RMTg. (B) cFos counts in the RMTg, EPN, and
LHb, were all higher than in rats receiving saline. cFos in the RMTg is signicantly
in high-avoiders compared to low-avoider rats, but not in EPN and LHb. (C) cFos
cells in the RMTg positively correlate with the mean run latency of the last 4 sessions
in high avoiders but not low avoiders. (D) RMTg neurons inhibition during the
rewarding phase of cocaine (0-15 minutes post-infusion), that did not dier between
high and low avoiders, but high avoiders showed signicantly higher RMTg ring
relative to low avoiders 15-45 minutes after cocaine infusion, overlapping the period
when cocaine is aversive. (E) Correlation analysis in individual rats revealed that
RMTg neuron responses 15-45 minutes but not 0-15 minutes post cocaine infusion
positively correlated with individual's runway latency. ** p<0.01; *** p<0.001.
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Figure 4.2: Glutamatergic inputs drive greater RMTg activation in brain slices
from high vs low cocaine avoider rats. (A) Patch-clamped VTA-projecting RMTg
neuron triple-labeled for biocytin (blue), retrograde tracer CTB-AF555 (red), and the
RMTg marker FoxP1 (green). (B-E) Relative to low-avoider rats (grey bars), VTA-
projecting RMTg neurons in high-avoiders (red bars) exhibited higher AMPA/NMDA
ratios (B) lower paired-pulse ratios (PPR) (C) greater inward rectication (R.I.)
(D)slower EPSC decay kinetics (E), and greater sensitivity to the CP-AMPAR blocker
NASPM (F), all consistent with increased pre- and post-synaptic signaling. * p<0.05;
** p<0.01.
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Figure 4.3: Manipulating GluR1 subunit of AMPA receptor modulates avoidance
behavior on the runway (A) Cannulas placements at the RMTg (B) Microinfusing
(B)2-pyrrolidinone or (C) NASPM in the RMTg increases or decreases run latencies
compared to a control group respectively. * p<0.05.
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Figure 4.4: PTEN downregulates glutamatergic signaling, and bidirectionally mod-
ulates cocaine-seeking. (A) Micro-infusing PTEN inhibitor VO-OHpic and RhoA
inhibitor Rhosin in the RMTg increase run latencies vs the RhoA inhibitor narcicla-
sine decreases run latencies. (B) Microinfusing narciclasine in a group of high-avoiders
before the runway dramatically reduces run latencies, and the eect gets carried over
to the next day, after which the latency recovers. (C) Run latencies by trial for the
dierent manipulations. (D) Bath application of narciclasine reduces amplitudes of
evoked EPSCs in RMTg and (E) reduces inward rectication. * p<0.05; *** p<0.001.
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Figure 4.5: RhoA/ROCK/PTEN pathway is upregulated in RMTg of low-avoiders.
(A) RhoA had the highest RMTg mRNA expression out of several ROCK activators
examined. (B) ROCK had the highest RMTg mRNA expression out of several RhoA
activators examined (C) Western blot of RMTg sections from high- and low-avoider
rats showed a down-regulation of p-GluR1-S831 in low-avoider rats. (D) Active RhoA
was upregulated in low-avoider rats compared to high-avoiders and control. * p<0.05.
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Chapter 5
Adaptations in NAshell Underlie
Individual Dierences in Cocaine
Avoidance
5.1 Introduction
Many studies have noted that VTA DA neurons increase their activity to rewarding
stimuli, and/or decrease it in response to aversive stimuli [Ungless et al., 2004, Calipari
et al., 2016, Danjo et al., 2014, Roitman et al., 2008]. In fact, recent studies have re-
vealed that optogenetic activation of GABAergic neurons and resultant inactivation of
DA neurons suppress reward consumption and induce an aversive response [Tan et al.,
2012, van Zessen et al., 2012]. In addition to noxious stimuli, midbrain DA neurons
appear to be actively inhibited by the absence of expected food rewards (or reward
omission) [Waelti et al., 2001, Tobler et al., 2003, Matsumoto and Hikosaka, 2007],
drug withdrawal [Diana et al., 1993], conditioned stimuli associated with lithium-
induced sickness [Mark et al., 1991]. These data are consistent with the idea that
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DA neuron inhibition encodes prediction errors involving negative incentive stimuli.
While VTA DA neurons project to multiple brain areas, the most prominent pathway
involved in this bidirectional encoding of reward and aversive stimuli is believed to
reside in the medial striatum. For example, a recent elegant study by Roitman et al.
stimulated a sensory pathway that can carry both positive and negative information
to show that opposing DA state in the NAshell is key for encoding opposing valences
stimuli [Roitman et al., 2008]. Particularly, Roitman et al., demonstrated that sucrose
rewards increase, while the aversive quinine suppressed the frequency of DA transients
in the NAshell [Roitman et al., 2008]. Indeed, while DA neurons respond to reward-
related events similarly regardless of their locations in A8, A9, and A10, DA neurons
projecting from the medial A10 to the ventromedial striatum appear to be impor-
tant for the aective component of stimulus-outcome learning or stimulus-incentive
learning. Specically, inhibition of DA neurons selectively in medial A10 neurons
(projecting to the ventromedial striatum, including medial accumbens shell) leads to
conditioned aversion, but not in lateral A10 (projecting to ventrolateral striatum) or
A9 neurons (projecting to dorsal striatum) [Liu et al., 2008].
Moreover, several studies have shown the suppression of DA neuron rings in re-
sponse to aversive stimuli, that in turn decreases DA levels in the NAshell, specically
promote the signal transmission in the indirect pathway through activated D2Rs, re-
sulting in avoidance behavior [Hikida et al., 2010, Hikida et al., 2013, Danjo et al.,
2014, Kravitz et al., 2012]. However, it is not clear whether this bi-directional en-
coding of reward and aversive behavioral response is true for cocaine, and to what
extent the dierences in this process correlate with individual dierences in cocaine
avoidance. Since RMTg neurons send strong inhibitory projections to DA neurons in
the VTA, which in turn project to the NAc, we wanted to investigate if this inuence
contributes to the encoding of aversive learning by decreasing DA and thus increas-
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ing D2-MSNs activity in the NAshell. Indeed, it has been already shown that RMTg
excitation reduces DA levels in the NAc [Taylor et al., 2019], and that RMTg hyper-
function accounts for depressive symptoms by reducing VTADA transmission onto
the NAshell of alcohol-withdrawn rats [Fu et al., 2019]. Therefore, we hypothesized
that individual dierences in RMTg inuences on VTA DA neurons, which modulate
the level of DA release in the NAshell, in turn drive dierences in NAshell D2-MSN
properties that contribute to cocaine avoidance.
5.2 Results
5.2.1 D2-like agonist/antagonist injections into the NAshell
reduce/increase motivation to seek cocaine in a runway
operant task.
As a preliminary attempt to examine whether a dip in DA transmission may disin-
hibit D2-MSNs to drive aversion to cocaine, we mimicked reductions or increases in D2
transmission by infusing the D2/3 receptor antagonist sulpiride (0.4 ug/0.5 ul per side)
or the D2/3 agonist quinpirole (0.4 ug/0.5 ul per side) directly in the NAshell. As ex-
pected, decreases D2R signaling with sulpiride increased, while increases D2R signal-
ing with quinpirole reduced, latencies to reach the goal box when compared to saline-
infused rats (one-way ANOVA, n=6-7 per group, F=11.8, p=0.0001; Tukey's test;
vehicle vs cocaine+quinpirole: p=0.37 ; vehicle vs cocaine + sulpiride: p=0.0221; co-
caine + sulpiride vs saline + sulpiride: p=0.0001) (Fig. 5.1E). Notably, sulpiride/quinpirole
were infused 10 minutes after the rats reached the goal box, shortly before the on-
set of RMTg activation and cocaine's aversive eects [Jhou et al., 2013, Li et al.,
2019a]. Furthermore, because infusions are given after animals complete each trial,
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these eects are independent of any possible eects of the drug on motor perfor-
mance or action selection, both of which occur before rats enter the goal box. These
results also suggest that D2 signaling might ultimately alter learning and the deci-
sion of whether or not to approach the reward based on the perceived value of the
two options. To further determine whether changes in D2-MSNs excitability corre-
late with cocaine aversion phenotypes, Jerey conducted patch clamp recordings in
saline-control, low-avoider, and high-avoider rats respectively. Strikingly, we found
that lower amounts of injected current were needed in order to evoke action potentials
in D2-MSNs from high-avoider versus low-avoider rats (Figure 3B). These results sug-
gest that D2 receptor signaling plays an important role in cocaine aversion, and that
similar to the RMTg individual dierences in neurons excitability correlates with the
cocaine avoidance phenotypes.
To further investigate the dierences between high and low-avoiders in D2, Jerey
examined whether individual behavioral dierences correlated with altered glutamate
transmission in D2-MSNs, as altered AMPA transmission and glutamate release onto
MSNs is one of the hallmarks of the transition from recreational to compulsive drug
use [Lüscher and Malenka, 2011, Britt and Bonci, 2013, Gipson et al., 2014, Grueter
et al., 2012, van Huijstee and Mansvelder, 2015, Morales and Pickel, 2012]. Hence,
we measured paired pulse ratios (PPR) and AMPA/NMDA ratios to assess changes
in pre- or postsynaptic glutamate transmission on D2-MSNs in the NAshell. Indeed,
we found that increased glutamate transmission correlated with decreased motiva-
tion to seek cocaine, consistent with prior ndings [Bock et al., 2013] (Fig. 5.1B).
Specically, we found that compared with saline-control and low-avoider rats the
AMPA/NMDA ratio in D2-MSNs was signicantly higher than in high-avoider rats
(One-way ANOVA: F (2,45) = 5.71, p <0.006; Bonferroni post-test, High-avoider vs
saline-control t = 3.029; p <0.05; High-avoiders vs Low-avoiders t = 2.665; p <0.05)
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(Fig5.1C). We also found a signicantly decreased PPR (One-way ANOVA F(2,45)
= 8.591, p = 0.0007), in high-avoiders compared to low-avoiders (t=5.609, p<0.05)
and saline control rats (t=4.192, p<0.05), suggesting increased presynaptic gluta-
mate release in the high avoiders. Hence, decreased cocaine-seeking in high-avoider
rats correlated with both presynaptic and post-synaptic potentiation of glutamate
transmission on D2-MSNs of the NAshell.
5.2.2 Cocaine-induced avoidance behavior correlates with im-
paired LTD at excitatory synapse in D2-MSNs of the
NAshell.
In addition to changes in synaptic strength, it is well accepted that saturation or
occlusion of long-term plasticity in the form of long-term depression (LTD) and
long-term potentiation (LTP) correlates with dierent phase of cocaine addiction
[Lüscher and Malenka, 2011, Britt and Bonci, 2013, Gipson et al., 2014, Grueter
et al., 2012, van Huijstee and Mansvelder, 2015, Morales and Pickel, 2012]. Notably,
it has been suggested that alterations in LTD in the NAc by cocaine might be a
key step in the cascade of neuroadaptations that lead to addiction. Therefore, we
examined whether LTD alterations in NAshell D2-MSNs correlate with decreased
cocaine-seeking in high-avoider rats. To induce LTD at excitatory synapses, we used
a spike-timing-dependent plasticity protocol previously known to involve D2R and
cannabinoid receptors (CB1) receptor activities in D2-MSNs of the striatum [Saun-
ders et al., 2013], and that mimics naturally occurring activity patterns in vivo,
making it a valuable tool to correlate behavior with neuronal plasticity. Interestingly,
we found that compared with saline-control rats and low-avoiders, spike-timing de-
pendent plasticity (STDP-LTD) was impaired in D2-MSNs in high-avoider rats (Fig.
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5.2B). Because previous reports [Saunders et al., 2013] demonstrated that this type
of plasticity requires CB1 receptor activation, we further characterized whether this
eect in high-avoider was due to altered signaling of any of these receptors. In sep-
arate experiments, we bath applied the CB1 receptor agonist win55212 (5uM) and
found that the sensitivity of the drug to induced LTD is reduced in high avoider, as
compared to low-avoider or saline rats in NAshell D2-MSNs (Fig. 5.2C). These results
further suggest that decreased LTD in NAshell D2MSNs may drive individual dier-
ences of the negative conditioning attributes of cocaine [Ettenberg, 2009, Ettenberg
et al., 1999, Jhou et al., 2013].
Indeed, it is known that D2 receptor activation increases the production/release of
endocannabinoid (eCB) [Giurida et al., 2001, Patel et al., 2003, Centonze et al., 2004]
that depress excitatory synapses in the striatum via CB1 activation [Kreitzer and
Malenka, 2005, Yin and Lovinger, 2006, Lovinger, 2008]. Therefore, we reasoned that
decreases in D2R signaling in the NAshell may drive cocaine aversion by reducing eCB
dependent depression at excitatory synapses in the NAshell. To test this hypothesis,
we infused the D2 antagonist sulpiride (0.4 ug/0.5 ul per side) into the NAshell with
or without the CB1 agonist win55212 (0.5 ug/0.5 ul per side) and demonstrated that
sulpiride alone decreases increases run latencies (consistent with greater avoidance)
and that this eect was blocked by the CB1 agonist (one-way ANOVA, n=6-7 per
group, F=13.03, p<0.0001; Tukey's test; cocaine + sulpiride vs cocaine + sulpiride
+ win55212: p=0.0001)(Fig. 5.2D).
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5.2.3 Cocaine-induced avoidance behavior correlates with in-
creased adenosine A2A receptor tone in D2-MSNs of the
NAshell.
We next decided to investigate the involvement of A2A receptors in mediating cocaine
avoidance behavior, as these receptors: 1) are heavily expressed in the striatum, where
they colocalize with D2 receptors on MSNs [Fink et al., 1992, Svenningsson et al.,
1998] 2) exert tonic inhibitory control over D2 receptor signaling within the striatum
[Farrar et al., 2010, Harper et al., 2006, Nagel et al., 2003, Weber et al., 2010] 3)
reduce eCB release and 4) drive LTP [Dias et al., 2012, d'Alcantara et al., 2001].
We therefore microinfused the A2A agonist CGS 21680 (0.4 ug/0.5 ul per side) into
the NAshell with or without cocaine and found that it dramatically increased run
latencies compared to vehicle microinfusion or to saline injections (one-way ANOVA,
n=6-7 per group, F=13.03, p<0.0001; Tukey's test; cocaine + vehicle vs cocaine +
CGS 21680: p=0.048 ; cocaine + CGS 21680 vs saline + CGS 21680: p=0.0016)
(Fig. 5.2D). We furthermore quantied D2 receptor and A2A receptor proteins in
the NAshell of high- and low-avoiders using western blots, and found that A2A was
upregulated in high-avoiders compared to low-avoiders or saline controls, whereas
D2 levels were not changed (Fig. 5.2E). Again, the protein quantication was only
acquired from one sample, which limits the interpretation of the results.
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5.2.4 RMTg inhibition reduces shock cue-induced decrease in
DA levels in the NAshell, without aecting reward or
neutral cues
To test whether RMTg modulates DA levels in the NAshell in response to a re-
ward/aversion predicting cue, we recorded the uorescence changes of an intensity-
based genetically encoded DA sensor (dLight1.2), in freely moving rats with ber
photometry, with or without inhibition of RMTg with baclofen/muscimol (Figure
5.3A), a cocktail of GABAA/GABAB agonists [Bowery et al., 1980, Andén et al.,
1979]. dLight1.2 enables optical readout of changes in DA concentration by cou-
pling the agonist binding-induced conformational changes in human DA receptors to
changes in the uorescence intensity of circularly permuted (cp) GFP derived from
GCaMP6 [Patriarchi et al., 2018]. We delivered an adeno associated virus encoding
dLight1.2 (AAV9-syn-dLight1.2) in the NAshell (Figure 5.3B), followed by implan-
tation of an optic ber for recordings. We trained the animals on a Pavlovian task
in which rats trained to associate distinct auditory cues with rewarding, neutral or
aversive outcomes (sucrose pellets, nothing or mild footshocks, respectively). We then
recorded DA levels in the NAshell in response to the cues and observed a sharp peak
in response to the reward cue and an inhibition in response to the aversive cue. How-
ever, after inhibition of RMTg with microinfusion of baclofen/muscimol, DA decrease
in response to the shock predictive cue was reduced, (Fig. 5.3 C, D) (Student t test:
n=4; t(47)=2.672; p=0.0122), whereas DA increase/decrease to the reward cue (Stu-
dent t test: n=4; t(47)=1.537; p=0.1313) (Fig. 5.3C, E) and neutral cue (Student
t test: n=4; t(47)=1.357; p=0.1811) (Fig. 5.3C, F) were not aected. Moreover,
uorescent readout in no virus control showed no changes in response to any of the
three cues. These results suggest that RMTg partly modulates the levels of DA in
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the NAshell in response to shock cue but not reward cue, consistent with previous
observations that demonstrated that RMTg inhibitions abolished VTA inhibition by
aversive stimuli, without altering their responses to reward cue [Li et al., 2019a].
5.2.5 High cocaine-avoiders have reduced early acquisition of
cocaine self-administration but higher rates of reinstate-
ment
Because we characterized cocaine avoidance thus far exclusively using an operant run-
way task, we next tested whether this phenotype predicts animals' behavior in a dif-
ferent operant task, a conventional leverpress self-administration paradigm. Interest-
ingly one study showed that resilience to develop cocaine addiction is characterized by
enhancement in glutamate transmission in the D2-MSNs of the ventral striatum [Bock
et al., 2013] while another group demonstrated as well that injecting an adenosine 2A
receptor agonist in the NAc prevented acquistion of self-administration [Knapp et al.,
2001, Wydra et al., 2018]. We therefore tested a new group of SD rats on the runway
task, then trained them to leverpress for cocaine, and found that run latencies corre-
lated negatively with lever pressing during the rst three days of self-administration
(n=22, r2=0.49, p=0.0003, bar graph: n=9-13 per group, t(20)=5.117, p<0.0001)
(Fig. 5.4A). However, all animals eventually met the acquisition criteria, and after 2
weeks of training, the mean number of cocaine infusions no longer correlated with run-
way latency, and did not dier between groups in the last 3 days of self-administration
(n=22, r2=0.015, p=0.59, bar graph: n=10-12 per group, t(20)=0.012, p=0.13) (Fig.
5.4B). We subsequently extinguished cocaine seeking behavior, and tested animals
on both cued-induced and drug-primed reinstatement. Surprisingly, high avoiders
were more likely to reinstate the extinguished cocaine seeking behavior compared
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to the low avoider group for both types of reinstatement (cued reinstatement: n=15,
r2=0.57, p=0.0011, bar graph: n=8 per group, t(13)=2.925, p=0.012, cocaine-primed
reinstatement: n=8, r2=0.60, p=0.02) (Fig. 5.4C and 5.4D).
5.3 Discussion
We have demonstrated that high- and low-avoiders exhibit dierences in D2 cells
of the NAshell after exposure to cocaine, where high-avoiders had higher D2 MSNs
excitability, upregulation of A2A receptor and had impaired eCB-mediated LTD.
Consequently, high-avoiders were less likely to acquire self-administration, consistent
with prior reports [Bock et al., 2013]. Finally we found that decreases in DA in
the NAshell in response to a shock predicting cue is mediated through RMTg. The
above results not only implicate the NAshell in mediating individual dierences in
run latencies, but also provide a likely downstream mechanism by which the RMTg
regulates behavioral output. In this view, dierences in neuronal excitability in the
VTA projecting RMTg pathway between high- and low-avoiders drive behavior by
inuencing downstream targets, particularly involving dopaminergic projections to
D2 MSN of the NAshell, consistent with a role of the RMTg to VTA projections
in the negative aect produced by noxious stimuli (including cocaine aversion)[Jhou
et al., 2013, Smith et al., 2019b, Li et al., 2019b].
Our results are in agreement with other studies that have shown that the NAshell
mediates avoidance behavior to noxious stimuli by activating D2 through decreased
DA release. Indeed manipulating D1 vs D2 results in opposite behavioral outputs.
Rewarding stimuli elicit a burst of phasic rings in DA neurons [Mirenowicz and
Schultz, 1994], and vastly increase synaptic concentrations of DA in the NAc [Tsai
et al., 2009, Di Chiara and Imperato, 1988]. This increase eectively activates the low-
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anity D1 receptors and results in induction of LTP in striatonigral neurons of the
direct pathway [Shen et al., 2008, Gerfen and Surmeier, 2011, Goto and Grace, 2005].
The simultaneous activation of the high-anity, inhibitory D2 receptors, however,
keeps the indirect pathway inactive. D1 receptor antagonist thus disrupts cocaine-
induced and reward-based behavior in a direct pathwayspecic manner. Aversive
stimuli on the other hand have been shown to reduce tonic rings of most DA neurons
[Brischoux et al., 2009, Ungless et al., 2004, Mirenowicz and Schultz, 1994, Coizet
et al., 2006], where blunting the tonic DA release in the ventromedial striatum leads to
conditioned place aversion. Particularly, an electric footshock been shown to inhibit
about 90 % of DA neurons in the VTA [Tan et al., 2012] and would reduce DA levels in
the NAc. This reduction in DA relieves the inhibitory actions of the high-anity D2
receptors but has no eects on the low-anity D1 receptors. The resultant selective
transmission enhancement in the indirect pathway would induce aversive learning.
RMTg predominantly projects to VTA DArgic neurons and inhibits these neurons
in response to shock and shock predictive cues [Li et al., 2019a]. It is thus not
surprising to nd that RMTg modulated DA levels in the NAshell in response to
shock cues, where RMTg inhibtion blunted the decrease of DA in response to a shock
predicting cue in the NAshell. Since acute cocaine exposure increases VTA-DA neuron
ring and DA release in limbic structure, and acute cocaine withdrawal decreases DA
neuronal activity [Kuhar et al., 1991, Ferris et al., 2014, Sulzer, 2011, Koeltzow and
White, 2003, Weiss et al., 1992] and since RMTg is a signicant source of inhibitory
input to the midbrain DA neurons, increased RMTg activity in high-avoiders could
account, at least in part, for the aversive learning that results from reduced activity
of DA neurons during acute withdrawal. And although we didn't test the role of
RMTg in modulating NAshell DA in response to cocaine directly, we hypothesize that
15 minutes after individual cocaine infusions (when cocaine becomes aversive) high-
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avoiders (but not low-avoiders) who have higher RMTg activation, would exhibit a dip
in DA transmission in the NAshell that disinhibits D2-MSNs, exerting an increased
inhibitory inuence on the DArgic cells of VTA, resulting in a hypodopaminergic state
that disinhibits D2-MSNs cells in the NAshell nucleus to drive avoidance behavior.
In contrast, low-avoiders would lack this D2-MSNs disinhibiting mechanism, and
therefore show less avoidance of cocaine. Such an interpretation is consistent with
previous studies showing that low DA levels in the ventral striatum guide behavior to
avoid aversive outcomes by disinhibits D2-MSNs [Danjo et al., 2014]. Of course, since
we used cannulas at the RMTg, a structure that does not exclusively project to the
VTA we cannot rule out the possibility that the decreased dip in DA with shock cue
can be an indirect result of RMTg inhibition. It would be crucial to follow up those
results with a pathway specic manipulation, using DREADDs to deactivate VTA-
projecting RMTg cells and to record from D2-MSNs in the NAshell using calcium
imaging in D2-cre rats, with and without RMTg inhibition.
Interestingly, we found that high-avoiders animals have upregulated A2A recep-
tor, and were less likely to acquire self-administration. These results are not only
consistent with the changes we observed in D2 MSNs [Danjo et al., 2014], but also
with the role of A2A in protecting against initiation of drug seeking [Knapp et al.,
2001]. These results again suggest that adenosine A2A receptor stimulation may op-
pose DA D2 receptor signaling in the NAshell that mediates cocaine seeking. Because
A2A has been shown to decrease eCB release and promote LTP, our working model
suggests that high-avoiders who have upregulated A2A receptor, on the one hand
prevent the release of eCB and thus blunt the LTD that develops in low-avoiders, and
on the other hand contribute in promoting LTP in D2 of high-avoiders. The question
of whether adenosine signaling can be used as a potential therapy in abuse disorders
remains to be answered. For example, several A2A antagonists have been developed
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for Parkinson's disease. The neurobiology of addiction has similarities to the neuro-
science of Parkinson's disease, where striatal DA signaling is also impaired [Jenner
et al., 2009]. A2A antagonists are being tested for Parkinson's disease specically to
increase DA signaling at the D2 receptor, and several compounds have been proven
to be safe for use in humans. To date, three medications (istradefylline, preladenant,
and tozadenant) have been used in human clinical trials. Although we showed that
high-avoiders have higher cocaine reinstatement compared to low-avoiders, we haven't
looked at the neurobiological dierences between high and low avoiders after self-
administration, extinction and reinstatement. However, it is worth mentioning some
studies that implicate A2A at those later stages. Indeed, human and animal studies
have consistently shown that addiction is accompanied by blunted DA signaling in
the striatum, and that the status of DA transmission predicts relapse or recovery from
addiction. Therefore, there is a consensus that manipulating this neurotransmission
system could be an ecient strategy to treat addiction. In particular, converging
evidence suggests that targeting D2R - i.e. enhancing its activity - would increase
the response rate to treatment by giving patients the boost they need to shift their
habits away from drug or alcohol use [Martinez et al., 2011, Trilie et al., 2013].
A promising way to increase signaling at the D2 receptor is by blocking the A2A
receptor. A2A receptors are closely linked to D2R and are able to modulate their sig-
naling [Ferré et al., 2016]. Blocking the A2A receptor potentiates the eect of DA at
the D2 receptor by facilitating the downstream cellular eects. Accordingly, studies in
rodents have shown that A2A antagonists can enhance DA-mediated processes, such
as reward-driven behaviors and motivation. More precisely, stimulation of adenosine
A2A receptors antagonizes reinstatement of cocaine seeking elicited by cocaine, DA
D2-receptor stimulation and cocaine-conditioned cues [Borroto-Escuela et al., 2015].
Based on these rodent studies, there has been a lot of interest in A2A antagonists for
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addiction research in humans, and one experiment using A2A antagonists for cocaine
dependence with functional MR scanning showed that this medication increased ac-
tivity in brain regions known to be hypoactive in cocaine addiction [Moeller et al.,
2012]. However, despite these promising data, there is no clinical trials testing A2A
antagonists for addiction. It would nonetheless be an interesting avenue to pursue,
after gaining a better understanding of the role of this receptor in the addiction phe-
notype. Moreover, the limited distribution of the receptor in the brain makes it a
valuable target in terms of targeted delivery and restriction of global side-eects of
medications.
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Figure 5.1: D2-like agonist/antagonist injections into the NAshell reduce/increase
motivation to seek cocaine in a runway operant task. (A) Schematic illustration of
the performed ex-vivo recording on D2-MSNs of D2-cre rats, (B) D2-MSNs displayed
increased excitability and (C) increased in AMPA/NMDA ratio. (D) NAshell can-
nulae placements. (E) Sulpiride increased, while quinpirole reduced run latencies. *
p<0.05, *** p<0.001.
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Figure 5.2: Cocaine-induced avoidance behavior correlates with impaired LTD at
excitatory synapse in D2-MSNs of the NAshell and upregulation of A2A receptor. (A)
PPR was signicantly decreased in high-avoiders vs low-avoiders and control. (B) D2-
MSNs displayed attenuated LTD, (C) and decreased CB1-LTD in high-avoiders rats
as compared with saline-control and low-avoiders. (D) The CB1 agonist Win55212
blocked sulpiride's eect on the runway, and A2A agonist increased run latencies.
(E) Western blot of NAshell collected from brains of high- and low-avoider animals
revealed an upregulation of A2A receptors compared to low-avoiders and control. (F)
Working model of our ndings * p<0.05, ** p<0.01.
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Figure 5.3: RMTg inhibition reduces shock cue decrease in DA levels in NAshell,
without aecting reward or neutral cue. (A) dLight1.2 was injected in the NAshell
and optical ber implanted at the same site. Cannulaes were implanted at the RMTg
for baclofen/muscimol injusion. (B) Virus and ber placements. (C) Peak uorescent
at cue onset showing (D) less DA decrease in response to shock cue when RMTg is
inhibited, whereas (E) reward and (F) neutral cues were not aected. * p<0.05.
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Figure 5.4: High cocaine-avoiders have reduced early acquisition of cocaine self-
administration but higher rates of reinstatement. (A) Latencies to obtain cocaine
(average of trials 4-7) correlated negatively with acquisition of lever pressing during
the rst three days of cocaine self-administration, and the number of presses on the
active lever was signicantly dierent between high and low avoiders. (B) Latencies to
obtain cocaine (average of trials 4-7) did not correlate with active lever pressing during
the last three days of cocaine self-administration, and the average number of cocaine
infusions during the last 3 days did not dier between high and low avoiders. Runway
latencies to obtain cocaine correlated positively with both cued (C) and cocaine-
primed (D) reinstatement lever pressing. * p<0.05, ** p<0.001, **** p<0.0001.
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Chapter 6
Discussion and Future Directions
6.1 Implications for Addiction and Reinstatement
Since the rst experimental demonstration that a drug of abuse supports instrumental
behavior, drugs have been discussed in the context of their rewarding eects, which
are assumed to drive and maintain drug-taking behavior. Indeed, drug reward has
been crucial in the development of most models of drug use, abuse, and addiction.
Over the last few decades, however, drugs of abuse have been increasingly recog-
nized as intricate compounds producing multiple stimulus eects, not all of which
are rewarding. The aversive eects of such drugs, for example, have been recognized
by a number of scientist working in the eld, although not many eorts have been
made to understand the role of these aversive eects in drug taking. We recognize
that the aversive eects of drugs should be taken into consideration in ongoing at-
tempts to model drug-taking behavior. Importantly, it has been suggested by several
researchers that drug taking may be a function of a delicate balance between drug
reward and withdrawal [Stolerman and d'Mello, 1981, Gaiardi et al., 1991b, Riley and
Simpson, 2001, Riley, 2011]. If so, the discussion of drug use and abuse requires the
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examination of both of these drug eects, their interaction, and the dierent factors
aecting them. In the present study, we present evidence in support of the inclusion
of the aversive eects of drugs in discussions of drug use and abuse. Even though we
haven't emphasized long-term adaptations occurring over weeks, months, and years,
the shorter-term eects examined here inuence addictive behavior, where immediate
aversive responses to acute drug withdrawal conferred a protective eect against ad-
diction and helped to slow or prevent the transition from casual to compulsive drug
use [Rezvani et al., 2010].
And although our study focused on characterizing individual dierence during
that initial phase of addiction and helped us identify protective factors, it would be
extremely useful to also understand the dierences that mark later phases of drug
addiction. Interestingly, we found that high-avoiders, that were initially protected
against addiction, had higher reinstatement compared to low-avoiders. High-avoiders
might indeed seek the drug more because in addition to seeking the rewarding eects
of cocaine, they might be motivated by alleviating withdrawal symtpoms/conditioned-
withdrawal to the cue. These ndings call to use the same approach that emphasizes
individual dierences in earlier stages and extend it to the stages of withdrawal and
reinstatement. Those stages might involve completely dierent molecular targets and
circuitry than the ones previously identied. Indeed, although RMTg has been shown
to be activated during cocaine withdrawal [Mahler and Aston-Jones, 2012], and might
contribute to the negative aect in withdrawal and drug-cravings, our lab has shown
that it does not promote reinstatement. On the contrary, RMTg stimulation during
cocaine-seeking produced enduring reductions in reinstatement (unpublished data).
Alternatively, we would be interested in looking at the circuitry underlying negative
reinforcement and, as a result, active avoidance. We mention "negative reinforce-
ment" here because external stimuli associated with environmental stress or drug
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withdrawal could be indeed viewed as negative reinforcers that contribute to instru-
mental drug seeking and consumption responses by strengthening behaviors that allow
escape from and/or avoidance of the aversive states elicited by these stimuli. One
study in particular showed that the Roman-high rats selected for rapid acquisition of
two-way active avoidance in the shuttle-box had higher reinstatement compared to
their low-avoidance rat lines which have poor acquisition of that same task [Fattore
et al., 2009], although the two lines were also dierent on many other phenotypes,
suggesting that reinstatement could be viewed as an active avoidance phenomenon
driven by negative reinforcement. However, little is known about the brain mech-
anisms involved and better understanding of the neural basis of escape/avoidance
behavior will provide important information that will allow a deeper understanding
of the role of aversive states in substance abuse. Moreover, since the little we know
about active avoidance suggests that it shares some common circuitry with reinstate-
ment [Martinez et al., 2013], [Ramirez et al., 2015], for future studies, we will shift
our focus towards investigating the circuitry involved in active avoidance and deter-
mine if the corresponding brain areas exhibit adaptive changes that correlate with
reinstatement. Specically, we will examine the contribution of the amygdala and the
contribution of anatomical outputs of key amygdala nuclei (especially the projection
from the basal amygdala to the nucleus accumbens) and the role of individual dier-
ences in fear and avoidance and their value in predicting susceptibility to addiction
and relapse.
6.2 Identication of Potential Therapeutics
As we have mentioned, aversive eects of drugs strongly inuence abuse potential.
For example, nicotine and alcohol both produce aversive eects that are particu-
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larly strong in some individuals, conferring on them protection against acquisition
of smoking and drinking habits. These protective eects are due in part to func-
tional variations in specic molecular targets, including alpha5 nicotinic receptors for
smoking, and an ALDH2 for drinking [Morton et al., 2018, Fowler et al., 2011, Wall
et al., 2000, Bierut et al., 2008]. Cocaine also produces aversive eects, which vary
between individuals, but unlike with nicotine or alcohol, the molecular processes reg-
ulating were still largely unexplored, hampering the search for novel treatments for
cocaine addiction, for which no FDA-approved medications exist [Maxwell, 2020].
Nowadays,the main treatments against psychostimulant addiction are focused on be-
havioral interventions [Phillips et al., 2014], with some pharmacological treatments
available for abstinent individuals [Tomko et al., 2018], which call for a better under-
standing of individual dierences in cocaine addiction propensity as a means to more
personalized treatment options.
Our study took advantage of the individual dierences in animal's responses to
one such factor that contributes to the likelihood to become addicted, aversion to
cocaine, to unveil underlying biomarkers, at dierent circuitry levels, that could be
used as potential treatments. Indeed, the concept of using drugs that potentiate
aversion to drugs has already been explored, as in the case of disulram (Antabuse)
which inhibits ADLH2, thereby reducing alcohol intake. For instance in the case
of cocaine, individuals who carry the "low-aversion" prole can be given a PTEN
inhibitor to be taken whenever drugs are consumed. Interestingly, if these ndings
can be extended to heroin, we could be able to apply them in a clinical settings
when giving pain medicine to patients, and take into account their vulnerability to
addiction when prescribing the drug. And nally, if we extend this approach to the
later stages of addiction, we could identify biomarkers that are involved in withdrawal
and drug cravings in addicted individuals that are motivated by these negative aects,
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and target them in treatment. For instance cocaine withdrawal in humans in the
outpatient setting is often characterized by severe depressive symptoms combined
with irritability, anxiety, and anhedonia lasting several hours to several days (i.e., the
crash) and may be one of the major motivating factors in the maintenance of the
cocaine-dependence cycle [Gawin and Kleber, 1986]. We could again use the prole of
the individual to identify what underlying mechanisms are potentially driving relapse
(drug withdrawal, depression, reward-seeking, punishment resistance etc) and provide
treatment accordingly.
Findings from this project may also help interpret genomic targets identied by
another ongoing collaborative study in our lab (1U01DA044468, as of April 2018)
that tackles a similar problem (individual dierences in cocaine avoidance) from a
very dierent angle, by examining DNA and mRNA correlates of behavioral dif-
ferences. Combining the ndings of this study with the next-generation DNA and
mRNA sequencing approach will help extend the ndings from this study, and po-
tentially discover previously unknown genetic correlates of addiction-propensity. As
a consequence, we can eventually, based on the genetic prole of the individual, tailor
treatments to individuals depending on their genetic prole.
Finally, we should keep in mind that addiction results from an interaction of a
panoply of underlying phenotypes, which makes the hope for nding a single highly
eective drug unlikely. Indeed, although a number of medications acting as agonists,
antagonists, or antidepressants have been evaluated in both animal models and hu-
mans, only limited success has come out of them [Carrera et al., 2001, Berger et al.,
1989, Maxwell, 2020], which suggests that pharmacological agents must be part of
a comprehensive approach toward treatment, targeting each one of the contributing
factors. This is where deconstructing addiction into its subcomponents is crucial.
Indeed, even though this study is focused on the aversive components of cocaine, our
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lab aims at identifying DNA and mRNA correlates of several other phenotypes that
have been shown to contribute to addiction propensity, such as exploratory behavior
and resistance to punishment. This comprehensive approach to understanding indi-
vidual dierences in drug addiction will allow us to understand molecular basis of
several phenotypes that dictate the course of addiction, and the interaction between
these phenotypes, which in turn would improve our understanding, prediction, and
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